Unnamed: 0.1,Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
1000,1000,,,5150390,[],CHEMBL1662853,Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP2B,B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.472,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,0.472
1001,1001,,,5150395,[],CHEMBL1662854,Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP2B,B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.023,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,0.023
1002,1002,,,5150400,[],CHEMBL1662855,Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP2B,B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,14.74,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,14.74
1003,1003,,,5150405,[],CHEMBL1662856,Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP2B,B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,1.656,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,1.656
1004,1004,,,5150410,[],CHEMBL1662857,Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP2B,B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.171,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,0.171
1005,1005,,,5150415,[],CHEMBL1662858,Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP2B,B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,1.164,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,1.164
1006,1006,,,5150420,[],CHEMBL1662859,Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.002,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.002
1007,1007,,,5150425,[],CHEMBL1662860,Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.004,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.004
1008,1008,,,5150430,[],CHEMBL1662861,Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.038,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.038
1009,1009,,,5150435,[],CHEMBL1662862,Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.048,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.048
1010,1010,,,5150440,[],CHEMBL1662863,Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.023,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.023
1011,1011,,,5150445,[],CHEMBL1662864,Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.047,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.047
1012,1012,,,5151534,[],CHEMBL1662986,Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.024,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.024
1013,1013,,,5151539,[],CHEMBL1662987,Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.021,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.021
1014,1014,,,5151544,[],CHEMBL1662988,Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP3,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649182,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326034,=,1,1,=,,IC50,ug.mL-1,,0.071,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.071
1015,1015,,,5151876,[],CHEMBL1662380,Antimicrobial activity against Proteus mirabilis 06-489 isolated from infected human urinary tract by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326063,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,4.0
1016,1016,,,5151877,[],CHEMBL1662382,Antimicrobial activity against Escherichia coli J53 transconjugated with Proteus mirabilis pHS10 carrying qnrC gene by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326063,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1017,1017,,,5151878,[],CHEMBL1662384,Antimicrobial activity against Escherichia coli J53 by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326063,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1018,1018,,,5154977,[],CHEMBL1665986,Antibacterial activity against Escherichia coli TOP10 harboring beta-lactamase RTG4 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
1019,1019,,,5154978,[],CHEMBL1665988,Antibacterial activity against Escherichia coli TOP10 harboring recombinant plasmid RTG4-S69 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1020,1020,,,5154979,[],CHEMBL1665990,Antibacterial activity against Escherichia coli TOP10 harboring recombinant plasmid RTG4-V49 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1021,1021,,,5154980,[],CHEMBL1666863,Antibacterial activity against Escherichia coli TOP10 harboring recombinant plasmid RTG4-S69-V49 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1022,1022,,,5154981,[],CHEMBL1666865,Antibacterial activity against Escherichia coli TOP10 harboring beta-lactamase RTG3 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1023,1023,,,5154982,[],CHEMBL1666867,Antibacterial activity against Escherichia coli TOP10 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1024,1024,,,5155023,[],CHEMBL1666881,Activity of recombinant beta-lactamase RTG4 expressed in Escherichia coli TOP10 by nitrocefin hydrolysis assay,B,,,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326751,<,1,0,<,,Kcat,/s,,0.01,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,0.01
1025,1025,,,5155024,[],CHEMBL1666882,Activity of recombinant beta-lactamase RTG4 expressed in Escherichia coli TOP10 by nitrocefin hydrolysis assay relative to benzylpenicillin,B,,,BAO_0001103,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1326751,<,1,0,<,,Activity,%,,0.01,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,0.01
1026,1026,,Not Determined,5155025,[],CHEMBL1666881,Activity of recombinant beta-lactamase RTG4 expressed in Escherichia coli TOP10 by nitrocefin hydrolysis assay,B,,,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649493,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326751,,1,0,,,Km,,,,CHEMBL612545,,Unchecked,,,,Km,,,,
1027,1027,,,5156850,[],CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325748,<,1,1,<,,MIC,ug.mL-1,,0.016,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC,ug ml-1,UO_0000274,,0.016
1028,1028,,,5156861,[],CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325748,=,1,1,=,,MIC50,ug.mL-1,,0.047,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC50,ug ml-1,UO_0000274,,0.047
1029,1029,,,5156872,[],CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325748,=,1,1,=,,MIC90,ug.mL-1,,0.094,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC90,ug ml-1,UO_0000274,,0.094
1030,1030,,,5156883,[],CHEMBL1661858,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent susceptible isolates by Etest method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1325748,=,1,0,=,,Activity,%,,99.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,Activity,%,UO_0000187,,99.0
1031,1031,,,5156894,[],CHEMBL1661859,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent intermediate isolates by Etest method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1325748,=,1,0,=,,Activity,%,,1.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,Activity,%,UO_0000187,,1.0
1032,1032,,,5156905,[],CHEMBL1662505,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent resistant isolates by Etest method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1325748,=,1,0,=,,Activity,%,,0.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,Activity,%,UO_0000187,,0.0
1033,1033,,,5157303,[],CHEMBL1660782,Activity of Salmonella enterica serotype Westhampton beta-lactamase CTX-M-53,B,,,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649429,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326171,=,1,0,=,,Kcat,/s,,292.0,CHEMBL1667678,Salmonella enterica subsp. enterica serovar Westhampton,Extended-spectrum beta-lactamase CTX-M-53,356621.0,,,Kcat,/s,,,292.0
1034,1034,,,5157313,[],CHEMBL1660783,Ratio of Kcat/Km for Salmonella enterica serotype Westhampton beta-lactamase CTX-M-53,B,,,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649429,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326171,=,1,0,=,,Kcat/Km,/s/microM,,3.6,CHEMBL1667678,Salmonella enterica subsp. enterica serovar Westhampton,Extended-spectrum beta-lactamase CTX-M-53,356621.0,,,Kcat/Km,/s/microM,,,3.6
1035,1035,,,5157329,[],CHEMBL1660782,Activity of Salmonella enterica serotype Westhampton beta-lactamase CTX-M-53,B,,,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649429,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1326171,=,1,1,=,,Km,nM,,80000.0,CHEMBL1667678,Salmonella enterica subsp. enterica serovar Westhampton,Extended-spectrum beta-lactamase CTX-M-53,356621.0,,,Km,uM,UO_0000065,,80.0
1036,1036,,,5158731,[],CHEMBL1662780,Ratio of MIC for beta-lactamase-negative methicillin-susceptible Staphylococcus aureus ATCC 25923 by microdilution method at pH 7.4 to ratio of MIC for beta-lactamase-negative methicillin-susceptible Staphylococcus aureus ATCC 25923 by microdilution method at pH 5.5,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326332,=,1,0,=,,FC,,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,16.0
1037,1037,,,5158732,[],CHEMBL1662781,Ratio of MIC for hospital-acquired methicillin-resistant Staphylococcus aureus ATCC 33591 by microdilution method at pH 7.4 to ratio of MIC for hospital-acquired methicillin-resistant Staphylococcus aureus ATCC 33591 by microdilution method at pH 5.5,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326332,=,1,0,=,,FC,,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,128.0
1038,1038,,,5158733,[],CHEMBL1662782,Ratio of MIC for hospital-acquired methicillin-resistant Staphylococcus aureus ATCC 33591 by microdilution method at pH 5.5 to MIC for beta-lactamase-negative methicillin-susceptible Staphylococcus aureus ATCC 25923 by microdilution method at pH 5.5,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326332,=,1,0,=,,FC,,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,4.0
1039,1039,,,5158734,[],CHEMBL1662783,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 infected in human keratinocytes assessed as bacterial count per mg of cell protein at low extracellular compound concentration after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326332,=,1,0,=,,log10cfu,,,3.23,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,3.23
1040,1040,,,5158735,[],CHEMBL1662784,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 infected in human keratinocytes assessed as bacterial count per mg of cell protein at high extracellular compound concentration after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326332,=,1,0,=,,log10cfu,,,-0.42,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,-0.42
1041,1041,,,5158736,[],CHEMBL1662785,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 infected in human keratinocytes assessed as change in bacterial count after 24 hrs,F,,,BAO_0000188,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326332,=,1,1,=,,EC50,ug.mL-1,,0.27,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,EC50,mg/L,UO_0000274,,0.27
1042,1042,,,5158737,[],CHEMBL1662786,Bacteriostatic activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 infected in human keratinocytes assessed as change in bacterial count after 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326332,=,1,0,=,,Activity,mg/L,,0.26,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mg/L,,,0.26
1043,1043,,,5158738,[],CHEMBL1662787,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 infected in human keratinocytes assessed as bacterial count per mg of cell protein at low extracellular compound concentration after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326332,=,1,0,=,,log10cfu,,,2.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,2.75
1044,1044,,,5158739,[],CHEMBL1662790,Bacteriostatic activity against methicillin-resistant Staphylococcus aureus ATCC 33591 infected in human keratinocytes assessed as change in bacterial count after 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649438,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1326332,=,1,0,=,,Activity,mg/L,,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mg/L,,,200.0
1045,1045,,,5159733,[],CHEMBL1663037,Antibacterial activity against Staphylococcus aureus E19977 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325766,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,2.0
1046,1046,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5159734,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '1000.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '1000.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1663039,"Cmax in human at 1000 mg, im",A,,,BAO_0002119,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1325766,=,1,1,=,,Cmax,nM,,61264.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,mg/L,UO_0000065,,26.0
1047,1047,,,5159735,[],CHEMBL1663043,"Protein binding in human serum at 1000 mg, im",A,,,BAO_0001103,BAO_0000366,cell-free format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1325766,=,1,0,=,,Activity,%,,30.0,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Activity,%,UO_0000187,,30.0
1048,1048,,,5159736,[],CHEMBL1663047,"Half life in human at 1000 mg, im",A,,,BAO_0002115,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Hour,1325766,=,1,1,=,,T1/2,hr,,1.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,1.5
1049,1049,,,5159752,[],CHEMBL1661769,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 20 mg/liter upto 24 hrs by time-kill study,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,>,1,0,>,,FC,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,2.0
1050,1050,,,5159758,[],CHEMBL1661764,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 2 mg/liter after 12 hrs by time-kill study,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,=,1,0,=,,FC,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,2.0
1051,1051,,,5159760,[],CHEMBL1661767,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 2 mg/liter upto 24 hrs by time-kill study,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,=,1,0,=,,FC,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,2.0
1052,1052,,,5159762,[],CHEMBL1661768,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 1.5 mg/liter upto 24 hrs by time-kill study,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,=,1,0,=,,FC,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,2.0
1053,1053,,Not Active,5159772,[],CHEMBL1661770,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 9 mg/liter after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1054,1054,,Not Active,5159776,[],CHEMBL1661771,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 2 mg/liter after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1055,1055,,Not Active,5159780,[],CHEMBL1661772,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 1.5 mg/liter after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1056,1056,,Not Active,5159784,[],CHEMBL1661773,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 20 mg/liter after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1057,1057,,Not Active,5159788,[],CHEMBL1661774,Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 0.5 mg/liter after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1058,1058,,Not Active,5159807,[],CHEMBL1661776,"Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in intracellular bacterial cfu in peritoneum at 200 mg/kg, sc administered 2 hrs after infection measured after 4 hrs",F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1059,1059,,Active,5159808,[],CHEMBL1661775,"Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in bacterial cfu in peritoneum at 200 mg/kg, sc administered 2 hrs after infection measured after 4 hrs",F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1060,1060,,Active,5159809,[],CHEMBL1661883,"Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in extracellular bacterial cfu in peritoneum at 200 mg/kg, sc administered 2 hrs after infection measured after 4 hrs",F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649157,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325766,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1061,1061,,,5163846,[],CHEMBL1654220,Antibacterial activity against Escherichia coli 1285 harboring beta-lactamase CMY-33 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1062,1062,,,5163855,[],CHEMBL1654221,Antibacterial activity against Escherichia coli YD006 harboring beta-lactamase CMY-33 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,=,1,1,=,,MIC,ug.mL-1,,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,96.0
1063,1063,,,5163864,[],CHEMBL1654222,Antibacterial activity against Escherichia coli 34943 harboring beta-lactamase CMY-44 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1064,1064,,,5163873,[],CHEMBL1654223,Antibacterial activity against Escherichia coli DH10B harboring plasmid BCSK carrying beta-lactamase CMY-33 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
1065,1065,,,5163882,[],CHEMBL1654224,Antibacterial activity against Escherichia coli DH10B harboring plasmid BCSK carrying beta-lactamase CMY-44 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
1066,1066,,,5163891,[],CHEMBL1654225,Antibacterial activity against Escherichia coli DH10B harboring plasmid BCSK carrying beta-lactamase CMY-2 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1067,1067,,,5163900,[],CHEMBL1654226,Antibacterial activity against Escherichia coli DH10B harboring plasmid BCSK by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649512,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326839,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.0
1068,1068,,,5163930,[],CHEMBL1655015,Antimicrobial activity against Stenotrophomonas maltophilia KJ by twofold serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649514,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326848,=,1,1,=,,MIC,ug.mL-1,,2048.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,2048.0
1069,1069,,,5163939,[],CHEMBL1655016,Antimicrobial activity against ampD1-deficient Stenotrophomonas maltophilia KJ by twofold serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649514,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326848,=,1,1,=,,MIC,ug.mL-1,,2048.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,2048.0
1070,1070,,,5163948,[],CHEMBL1655017,Antimicrobial activity against ampD2-deficient Stenotrophomonas maltophilia KJ by twofold serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649514,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326848,=,1,1,=,,MIC,ug.mL-1,,2048.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,2048.0
1071,1071,,,5163957,[],CHEMBL1655018,"Antimicrobial activity against ampD1-, ampD2-deficient Stenotrophomonas maltophilia KJ by twofold serial agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649514,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326848,=,1,1,=,,MIC,ug.mL-1,,2048.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,2048.0
1072,1072,,,5164725,[],CHEMBL1665013,Antibacterial activity against Campylobacter jejuni isolate P338 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1073,1073,,,5164737,[],CHEMBL1665014,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P790 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1074,1074,,,5164750,[],CHEMBL1665015,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1093 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1075,1075,,,5164761,[],CHEMBL1665016,Antibacterial activity against Campylobacter jejuni isolate P1093 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1076,1076,,,5164773,[],CHEMBL1665017,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1618 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,256.0
1077,1077,,,5164786,[],CHEMBL1665018,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1650 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1078,1078,,,5164799,[],CHEMBL1665019,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P1730 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1079,1079,,,5164812,[],CHEMBL1665880,Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1698 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1080,1080,,,5164825,[],CHEMBL1665881,Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1699 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1081,1081,,,5164838,[],CHEMBL1665882,Antibacterial activity against bla gene-negative and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P843 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1082,1082,,,5164851,[],CHEMBL1665883,Antibacterial activity against bla gene-negative and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P854 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1083,1083,,,5164864,[],CHEMBL1665884,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter coli isolate P321 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,,MIC,ug ml-1,UO_0000274,,64.0
1084,1084,,,5164877,[],CHEMBL1665885,Antibacterial activity against bla-positive and beta-lactamase-weakly positive Campylobacter coli isolate P1627 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,,MIC,ug ml-1,UO_0000274,,64.0
1085,1085,,,5164889,[],CHEMBL1665886,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter coli isolate P1826 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,,MIC,ug ml-1,UO_0000274,,64.0
1086,1086,,,5168274,[],CHEMBL1659627,Antibacterial activity against Klebsiella pneumoniae 05-560 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,256.0
1087,1087,,,5168288,[],CHEMBL1659628,Antibacterial activity against Escherichia coli TOP10 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1088,1088,,,5168301,[],CHEMBL1659629,Antibacterial activity against Escherichia coli TOP10 harboring beta-lactamase NDM-1 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1089,1089,,,5168315,[],CHEMBL1659630,Antibacterial activity against Escherichia coli J53 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1090,1090,,,5168329,[],CHEMBL1659631,Antibacterial activity against Escherichia coli J53 harboring beta-lactamase NDM-1 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1091,1091,,,5168343,[],CHEMBL1659632,Antibacterial activity against Escherichia coli NF-NDM-1 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322938,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1092,1092,,,5168356,[],CHEMBL1659633,Activity of Klebsiella pneumoniae 05-560 beta-lactamase NDM-1 by spectrophotometry,B,,,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1322938,=,1,1,=,,Km,nM,,8000.0,CHEMBL1667695,Klebsiella pneumoniae,Beta-lactamase NDM-1,573.0,,,Km,uM,UO_0000065,,8.0
1093,1093,,,5168367,[],CHEMBL1659634,Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase NDM-1,B,,,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322938,=,1,0,=,,Kcat/Km,/s/microM,,0.61,CHEMBL1667695,Klebsiella pneumoniae,Beta-lactamase NDM-1,573.0,,,Kcat/Km,/s/microM,,,0.61
1094,1094,,,5168377,[],CHEMBL1659635,Activity of Klebsiella pneumoniae 05-560 beta-lactamase IMP1 by spectrophotometry,B,,,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1322938,=,1,1,=,,Km,nM,,37000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,37.0
1095,1095,,,5168388,[],CHEMBL1659636,Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase IMP1,B,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322938,=,1,0,=,,Kcat/Km,/s/microM,,0.22,CHEMBL612545,,Unchecked,,,,Kcat/Km,/s/microM,,,0.22
1096,1096,,,5168398,[],CHEMBL1659763,Activity of Klebsiella pneumoniae 05-560 beta-lactamase VIM2 by spectrophotometry,B,,,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1322938,=,1,1,=,,Km,nM,,22000.0,CHEMBL1667696,Klebsiella pneumoniae,Metallo-beta-lactamase VIM-2,573.0,,,Km,uM,UO_0000065,,22.0
1097,1097,,,5168408,[],CHEMBL1659764,Ratio of Kcat to Km for Klebsiella pneumoniae 05-560 beta-lactamase VIM2,B,,,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322938,=,1,0,=,,Kcat/Km,/s/microM,,0.55,CHEMBL1667696,Klebsiella pneumoniae,Metallo-beta-lactamase VIM-2,573.0,,,Kcat/Km,/s/microM,,,0.55
1098,1098,,,5168419,[],CHEMBL1659633,Activity of Klebsiella pneumoniae 05-560 beta-lactamase NDM-1 by spectrophotometry,B,,,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322938,=,1,0,=,,Kcat,/s,,5.0,CHEMBL1667695,Klebsiella pneumoniae,Beta-lactamase NDM-1,573.0,,,Kcat,/s,,,5.0
1099,1099,,,5168429,[],CHEMBL1659635,Activity of Klebsiella pneumoniae 05-560 beta-lactamase IMP1 by spectrophotometry,B,,,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322938,=,1,0,=,,Kcat,/s,,8.0,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,8.0
1100,1100,,,5168439,[],CHEMBL1659763,Activity of Klebsiella pneumoniae 05-560 beta-lactamase VIM2 by spectrophotometry,B,,,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649278,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322938,=,1,0,=,,Kcat,/s,,12.0,CHEMBL1667696,Klebsiella pneumoniae,Metallo-beta-lactamase VIM-2,573.0,,,Kcat,/s,,,12.0
1101,1101,,,5170231,[],CHEMBL1663502,Drug absorption in human assessed as human intestinal absorption rate,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649380,Eur J Med Chem,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1325439,=,1,0,=,,log10(%HIA +10),,,1.176,CHEMBL612558,,ADMET,,,,log10(%HIA +10),,,,1.176
1102,1102,,,5171039,[],CHEMBL1652763,Activity at Chryseobacterium indologenes 597 metallo-beta-lactamase IND-6 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,B,,,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322398,=,1,0,=,,Kcat,/s,,75.0,CHEMBL1667689,Chryseobacterium indologenes,Metallo-beta-lactamase IND-6,253.0,,,Kcat,/s,,,75.0
1103,1103,,,5171053,[],CHEMBL1652763,Activity at Chryseobacterium indologenes 597 metallo-beta-lactamase IND-6 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,B,,,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1322398,=,1,1,=,,Km,nM,,23000.0,CHEMBL1667689,Chryseobacterium indologenes,Metallo-beta-lactamase IND-6,253.0,,,Km,uM,UO_0000065,,23.0
1104,1104,,,5172093,[],CHEMBL1652764,Ratio of Kcat to Km for Chryseobacterium indologenes 597 metallo-beta-lactamase IND-6 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,B,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322398,=,1,0,=,,Kcat/Km,10'6/M/s,,3.3,CHEMBL1667689,Chryseobacterium indologenes,Metallo-beta-lactamase IND-6,253.0,,,Kcat/Km,10'6/M/s,,,3.3
1105,1105,,,5172121,[],CHEMBL1652767,Ratio of Kcat to Km for Chryseobacterium meningosepticum CCUG 4310 beta-lactamase BlaB1 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,B,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322398,=,1,0,=,,Kcat/Km,10'6/M/s,,1.0,CHEMBL1667692,Flavobacterium meningosepticum,Carbapenem-hydrolyzing beta-lactamase BlaB-1,238.0,,,Kcat/Km,10'6/M/s,,,1.0
1106,1106,,,5172135,[],CHEMBL1652754,Antimicrobial activity against Chryseobacterium indologenes 597 expressing metallo-beta-lactamase IND-6 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322398,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL613343,Chryseobacterium indologenes,Chryseobacterium indologenes,253.0,,,MIC,ug ml-1,UO_0000274,,64.0
1107,1107,,,5172136,[],CHEMBL1652757,Antimicrobial activity against Escherichia coli DH5alpha harboring metallo-beta-lactamase IND-6 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322398,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
1108,1108,,,5172137,[],CHEMBL1652760,Antimicrobial activity against Escherichia coli DH5alpha harboring plasmid pBC-SK after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649237,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322398,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1109,1109,,,5180867,[],CHEMBL1659346,Antimicrobial activity against Acinetobacter baumannii KI by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,256.0
1110,1110,,,5180868,[],CHEMBL1659347,Antimicrobial activity against Acinetobacter baumannii CIP70.10 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
1111,1111,,,5180869,[],CHEMBL1659348,Antimicrobial activity against Acinetobacter baumannii AYE expressing VEB-1 gene by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,256.0
1112,1112,,,5180870,[],CHEMBL1659349,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-33 plasmid by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1113,1113,,,5180871,[],CHEMBL1659350,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-50 plasmid by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
1114,1114,,,5180872,[],CHEMBL1659351,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-11 plasmid by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
1115,1115,,,5180873,[],CHEMBL1659352,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-33 plasmid with entire blaAmpC gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1116,1116,,,5180874,[],CHEMBL1659353,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-11 plasmid with entire blaAmpC gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1117,1117,,,5180875,[],CHEMBL1659354,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-33 plasmid with entire blaAmpC gene with alanine residue deletion at 215 position by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1118,1118,,,5180876,[],CHEMBL1659355,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-11 plasmid carrying entire blaAmpC gene with alanine residue insertion at 215 position by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1119,1119,,,5180877,[],CHEMBL1659356,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-33 plasmid carrying entire blaAmpC gene with alanine residue deletion at 215 position and R210P substitution by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1120,1120,,,5180878,[],CHEMBL1659357,Antimicrobial activity against Escherichia coli TOP10 harboring pADC-11 plasmid carrying entire blaAmpC gene with alanine residue insertion at 215 position and R210P substitution by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1121,1121,,,5180879,[],CHEMBL1659358,Antimicrobial activity against Escherichia coli TOP10 harboring pTOPO plasmid by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649315,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323744,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1122,1122,,,5181294,[],CHEMBL1665519,Antibacterial activity against 5 x 10'5 CFU/ml CMY-30 producing Escherichia coli MC4100 harboring plasmid AC-cmy30 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649546,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327094,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1123,1123,,,5181295,[],CHEMBL1665520,Antibacterial activity against 5 x 10'5 CFU/ml CMY-2 producing Escherichia coli MC4100 harboring plasmid AC-cmy2 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649546,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327094,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1124,1124,,,5181296,[],CHEMBL1665521,Antibacterial activity against 5 x 10'5 CFU/ml Escherichia coli MC4100 harboring plasmid ACYC184 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649546,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327094,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1125,1125,,,5183009,[],CHEMBL1654491,Ratio of Kcat to Km for Klebsiella pneumoniae AH24-270 CTX-M-71 beta-lactamase,B,,,BAO_0000193,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322297,=,1,0,=,,Ratio,,,0.1,CHEMBL1667693,Klebsiella pneumoniae,Extended spectrum beta-lactamase CTX-M-71,573.0,,,Ratio,,,,0.1
1126,1126,,,5183025,[],CHEMBL1654492,Ratio of Kcat to Km for Klebsiella pneumoniae AH27 CTX-M-15 beta-lactamase,B,,,BAO_0000193,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322297,=,1,0,=,,Ratio,,,0.25,CHEMBL1667694,Klebsiella pneumoniae,Beta-lactamase AH27 CTX-M-15,573.0,,,Ratio,,,,0.25
1127,1127,,,5183047,[],CHEMBL1654473,Antimicrobial activity against Escherichia coli K-12 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1128,1128,,,5183066,[],CHEMBL1654476,Antimicrobial activity against Escherichia coli DH5[alpha] by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
1129,1129,,,5183084,[],CHEMBL1654489,Activity of Klebsiella pneumoniae AH24-270 CTX-M-71 beta-lactamase,B,,,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322297,=,1,0,=,,Kcat,/s,,8.8,CHEMBL1667693,Klebsiella pneumoniae,Extended spectrum beta-lactamase CTX-M-71,573.0,,,Kcat,/s,,,8.8
1130,1130,,,5183096,[],CHEMBL1654490,Activity of Klebsiella pneumoniae AH27 CTX-M-15 beta-lactamase,B,,,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1322297,=,1,0,=,,Kcat,/s,,45.0,CHEMBL1667694,Klebsiella pneumoniae,Beta-lactamase AH27 CTX-M-15,573.0,,,Kcat,/s,,,45.0
1131,1131,,,5183107,[],CHEMBL1654489,Activity of Klebsiella pneumoniae AH24-270 CTX-M-71 beta-lactamase,B,,,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1322297,=,1,1,=,,Km,nM,,85000.0,CHEMBL1667693,Klebsiella pneumoniae,Extended spectrum beta-lactamase CTX-M-71,573.0,,,Km,uM,UO_0000065,,85.0
1132,1132,,,5183113,[],CHEMBL1654490,Activity of Klebsiella pneumoniae AH27 CTX-M-15 beta-lactamase,B,,,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1322297,=,1,1,=,,Km,nM,,180000.0,CHEMBL1667694,Klebsiella pneumoniae,Beta-lactamase AH27 CTX-M-15,573.0,,,Km,uM,UO_0000065,,180.0
1133,1133,,,5183118,[],CHEMBL1654472,Antimicrobial activity against Escherichia coli K-12 transconjugant harboring blaCTX-M-71 gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1134,1134,,,5183124,[],CHEMBL1654471,Antimicrobial activity against Klebsiella pneumoniae AH24-270 expressing blaCTX-M-71 gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,512.0
1135,1135,,,5183127,[],CHEMBL1654474,Antimicrobial activity against Escherichia coli DH5[alpha] harboring pBC-CTX-M-71 plasmid by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1136,1136,,,5183129,[],CHEMBL1654475,Antimicrobial activity against Escherichia coli DH5[alpha] harboring pBC-CTX-M-15 plasmid by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649220,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322297,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1137,1137,,,5185474,[],CHEMBL1664999,Antibacterial activity against Campylobacter jejuni by NCCLS agar doubling dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC50,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC50,ug ml-1,UO_0000274,,128.0
1138,1138,,,5185475,[],CHEMBL1664999,Antibacterial activity against Campylobacter jejuni by NCCLS agar doubling dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC90,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1139,1139,,,5185476,[],CHEMBL1664999,Antibacterial activity against Campylobacter jejuni by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,1.0
1140,1140,,,5185525,[],CHEMBL1665000,Antibacterial activity against Campylobacter coli by NCCLS agar doubling dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC50,ug.mL-1,,128.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,,MIC50,ug ml-1,UO_0000274,,128.0
1141,1141,,,5185526,[],CHEMBL1665000,Antibacterial activity against Campylobacter coli by NCCLS agar doubling dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,,MIC90,ug ml-1,UO_0000274,,256.0
1142,1142,,,5185527,[],CHEMBL1665000,Antibacterial activity against Campylobacter coli by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,,MIC,ug ml-1,UO_0000274,,64.0
1143,1143,,,5185553,[],CHEMBL1665003,Antibacterial activity against bla gene-positive and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni NCTC 11168 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,32.0
1144,1144,,,5185565,[],CHEMBL1665004,Antibacterial activity against Campylobacter jejuni isolate P270 harboring blaOXA-61::cat gene by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1145,1145,,,5185577,[],CHEMBL1665005,Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P835 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1146,1146,,,5185590,[],CHEMBL1665006,Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P850 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1147,1147,,,5185603,[],CHEMBL1665007,Antibacterial activity against bla gene-negative and nitrocefin reaction-negative beta-lactamase harboring Campylobacter jejuni isolate P1962 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1148,1148,,,5185616,[],CHEMBL1665008,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P285 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1149,1149,,,5185629,[],CHEMBL1665009,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P286 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1150,1150,,,5185642,[],CHEMBL1665010,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P305 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1151,1151,,,5185655,[],CHEMBL1665011,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P316 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,64.0
1152,1152,,,5185668,[],CHEMBL1665012,Antibacterial activity against bla gene-positive and nitrocefin reaction-positive beta-lactamase harboring Campylobacter jejuni isolate P338 by NCCLS agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1649560,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327163,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,,MIC,ug ml-1,UO_0000274,,128.0
1153,1153,,,5212126,[],CHEMBL1678645,Antibacterial activity against 10'7 CFU/ml wild-type Listeria monocytogenes EGD-e Serovar 1/2a at 30 ug after 16 hrs by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Millimeter,1332649,=,1,1,=,,IZ,mm,,21.1,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,IZ,mm,UO_0000016,,21.1
1154,1154,,,5212131,[],CHEMBL1678842,Antibacterial activity against 10'7 CFU/ml telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a at 30 ug after 16 hrs by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Millimeter,1332649,=,1,1,=,,IZ,mm,,24.4,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,IZ,mm,UO_0000016,,24.4
1155,1155,,,5212137,[],CHEMBL1678847,Antibacterial activity against 10'5 CFU/ml wild-type Listeria monocytogenes EGD-e Serovar 1/2a after 16 hrs by by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332649,=,1,1,=,,MIC,ug.mL-1,,2.87,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,2.87
1156,1156,,,5212142,[],CHEMBL1678849,Antibacterial activity against 10'5 CFU/ml telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a after 16 hrs by by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332649,=,1,1,=,,MIC,ug.mL-1,,1.44,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,1.44
1157,1157,,,5212146,[],CHEMBL1678850,Ratio of MIC wild-type Listeria monocytogenes EGD-e Serovar 1/2a to MIC for telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671746,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1332649,>,1,0,>,,FC,,,2.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,FC,,,,2.0
1158,1158,,,5213064,[],CHEMBL1677043,Antimicrobial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,36.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,36.1
1159,1159,,,5213147,[],CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,2.0
1160,1160,,,5213155,[],CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,4.0
1161,1161,,,5213156,[],CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
1162,1162,,,5213157,[],CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
1163,1163,,,5213174,[],CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
1164,1164,,,5213177,[],CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
1165,1165,,,5213179,[],CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
1166,1166,,,5213181,[],CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
1167,1167,,,5213300,[],CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
1168,1168,,,5213302,[],CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1169,1169,,,5213305,[],CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
1170,1170,,,5213310,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
1171,1171,,,5213313,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1172,1172,,,5213316,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
1173,1173,,,5213320,[],CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1174,1174,,,5213323,[],CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
1175,1175,,,5213345,[],CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
1176,1176,,,5213346,[],CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
1177,1177,,,5213361,[],CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
1178,1178,,,5213363,[],CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
1179,1179,,,5213366,[],CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
1180,1180,,,5213369,[],CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
1181,1181,,,5214441,[],CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
1182,1182,,,5214442,[],CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
1183,1183,,,5214443,[],CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332157,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
1184,1184,,,5214456,[],CHEMBL1677044,Antimicrobial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
1185,1185,,,5214467,[],CHEMBL1677045,Antimicrobial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,9.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,9.6
1186,1186,,,5214478,[],CHEMBL1677046,Antimicrobial activity against Streptococcus pneumoniae serotype 7F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,9.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,9.6
1187,1187,,,5214490,[],CHEMBL1677047,Antimicrobial activity against Streptococcus pneumoniae serotype 11A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,95.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,95.2
1188,1188,,,5214502,[],CHEMBL1677048,Antimicrobial activity against Streptococcus pneumoniae serotype 6C assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,47.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,47.5
1189,1189,,,5214514,[],CHEMBL1677049,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
1190,1190,,,5214526,[],CHEMBL1677050,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
1191,1191,,,5214538,[],CHEMBL1677051,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
1192,1192,,,5214569,[],CHEMBL1677175,Antimicrobial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,91.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,91.4
1193,1193,,,5214570,[],CHEMBL1677176,Antimicrobial activity against Streptococcus pneumoniae serotype 22F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
1194,1194,,,5214571,[],CHEMBL1677179,Antimicrobial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,96.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,96.4
1195,1195,,,5214572,[],CHEMBL1677177,Antimicrobial activity against Streptococcus pneumoniae serotype 23B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,96.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,96.8
1196,1196,,,5214573,[],CHEMBL1677178,Antimicrobial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1332157,=,1,0,=,,Activity,%,,20.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,20.7
1197,1197,,,5228663,[],CHEMBL1676213,Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1332508,=,1,0,=,,FC,,,2.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,FC,,,,2.0
1198,1198,,,5228677,[],CHEMBL1676214,Antimicrobial activity against Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332508,=,1,1,=,,MIC,ug.mL-1,,2.87,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,2.87
1199,1199,,,5228678,[],CHEMBL1676215,Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332508,=,1,1,=,,MIC,ug.mL-1,,1.44,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,1.44
1200,1200,,,5228713,[],CHEMBL1678230,Antimicrobial activity against Listeria monocytogenes EGD-e at 30 ug after 16 hrs by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Millimeter,1332508,=,1,1,=,,IZ,mm,,21.3,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,IZ,mm,UO_0000016,,21.3
1201,1201,,,5228714,[],CHEMBL1676212,Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e at 30 ug after 16 hrs by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671725,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Millimeter,1332508,=,1,1,=,,IZ,mm,,24.8,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,IZ,mm,UO_0000016,,24.8
1202,1202,,,5229403,[],CHEMBL1679887,Antimicrobial activity against Escherichia coli MC4100 harboring a weak promoter in beta-lactamase GES-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1203,1203,,,5229404,[],CHEMBL1679888,Antimicrobial activity against Escherichia coli MC4100 harboring strong promoter in beta-lactamase GES-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1204,1204,,,5229405,[],CHEMBL1679889,Antimicrobial activity against Escherichia coli MC4100 harboring promoter hybrid 1 in beta-lactamase GES-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
1205,1205,,,5229406,[],CHEMBL1679890,Antimicrobial activity against Escherichia coli MC4100 harboring promoter hybrid 2 in beta-lactamase GES-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
1206,1206,,,5229407,[],CHEMBL1679891,Antimicrobial activity against Escherichia coli MC4100 harboring weak promoter and active promoter P2 in beta-lactamase GES-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,,MIC,ug.mL-1,,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,96.0
1207,1207,,,5229408,[],CHEMBL1679892,Antimicrobial activity against Escherichia coli MC4100 harboring strong promoter and active promoter P2 in beta-lactamase GES-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1208,1208,,,5229409,[],CHEMBL1679893,Antimicrobial activity against Escherichia coli MC4100 harboring promoter hybrid 1 and active promoter P2 in beta-lactamase GES-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1209,1209,,,5229410,[],CHEMBL1679894,Antimicrobial activity against Escherichia coli MC4100 expressing promoterless beta-lactamase GES-1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1671643,Antimicrob Agents Chemother,2009.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331928,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1210,1210,,,5298424,[],CHEMBL1697380,Antimicrobial activity against Escherichia coli XL1-Blue harboring pLBII-VIM-2 plasmid expressing VIM-2 beta-lactamase by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1211,1211,,,5298425,[],CHEMBL1697379,Antimicrobial activity against Escherichia coli XL1-Blue harboring pLBII-VIM-2 plasmid expressing VIM-2 A64W mutant beta-lactamase by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1212,1212,,,5298426,[],CHEMBL1697378,Antimicrobial activity against Escherichia coli XL1-Blue harboring pLBII-VIM-2 plasmid expressing VIM-2 W87F mutant beta-lactamase by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1213,1213,,,5298427,[],CHEMBL1697377,Antimicrobial activity against Escherichia coli XL1-Blue harboring pLBII-VIM-2 plasmid expressing VIM-2 W87A mutant beta-lactamase by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1214,1214,,,5298428,[],CHEMBL1697375,Antimicrobial activity against Escherichia coli XL1-Blue harboring pBC-SK plasmid by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337786,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1215,1215,,,5298491,[],CHEMBL1697376,Activity of Escherichia coli XL1-Blue wild-type VIM-2 beta-lactamase by spectrophotometer,B,,,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat,/s,,8.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Kcat,/s,,,8.0
1216,1216,,,5298492,[],CHEMBL1697374,Activity of Escherichia coli XL1-Blue VIM-2 A64W mutant beta-lactamase by spectrophotometer,B,,,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat,/s,,15.0,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,15.0
1217,1217,,,5298493,[],CHEMBL1697373,Activity of Escherichia coli XL1-Blue wild-type IMP-1 beta-lactamase by spectrophotometer,B,,,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat,/s,,8.0,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,8.0
1218,1218,,,5298494,[],CHEMBL1697371,Ratio of Kcat to Km for Escherichia coli XL1-Blue wild-type VIM-2 beta-lactamase by spectrophotometer,B,,,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat/Km,uM/hr,,0.4,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Kcat/Km,uM/hr,,,0.4
1219,1219,,,5298495,[],CHEMBL1697234,Ratio of Kcat to Km for Escherichia coli XL1-Blue VIM-2 A64W mutant beta-lactamase by spectrophotometer,B,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat/Km,uM/hr,,3.7,CHEMBL612545,,Unchecked,,,,Kcat/Km,uM/hr,,,3.7
1220,1220,,,5298496,[],CHEMBL1697370,Ratio of Kcat to Km for Escherichia coli XL1-Blue wild-type IMP-1 beta-lactamase by spectrophotometer,B,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat/Km,uM/hr,,0.22,CHEMBL612545,,Unchecked,,,,Kcat/Km,uM/hr,,,0.22
1221,1221,,,5298534,[],CHEMBL1697376,Activity of Escherichia coli XL1-Blue wild-type VIM-2 beta-lactamase by spectrophotometer,B,,,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,,Km,nM,,20000.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Km,uM,UO_0000065,,20.0
1222,1222,,,5298542,[],CHEMBL1697374,Activity of Escherichia coli XL1-Blue VIM-2 A64W mutant beta-lactamase by spectrophotometer,B,,,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,,Km,nM,,4000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,4.0
1223,1223,,,5298551,[],CHEMBL1697373,Activity of Escherichia coli XL1-Blue wild-type IMP-1 beta-lactamase by spectrophotometer,B,,,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,,Km,nM,,37000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,37.0
1224,1224,,,5299312,[],CHEMBL1697232,Activity of Escherichia coli BL21(DE3) wild-type VIM-2 beta-lactamase by spectrophotometer,B,,,BAO_0000481,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat,/s,,8.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Kcat,/s,,,8.0
1225,1225,,,5299313,[],CHEMBL1697231,Activity of Escherichia coli BL21(DE3) VIM-2 W87F mutant beta-lactamase by spectrophotometer,B,Q5U7L7,W87F,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,1,,1337786,=,1,0,=,,Kcat,/s,,12.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Kcat,/s,,,12.0
1226,1226,,,5299314,[],CHEMBL1697230,Activity of Escherichia coli BL21(DE3) VIM-2 W87A mutant beta-lactamase by spectrophotometer,B,Q5U7L7,W87A,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat,/s,,15.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Kcat,/s,,,15.0
1227,1227,,,5299315,[],CHEMBL1697229,Ratio of Kcat to Km for Escherichia coli BL21(DE3) wild-type VIM-2 beta-lactamase by spectrophotometer,B,,,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat/Km,/uM/s,,0.4,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Kcat/Km,/uM/s,,,0.4
1228,1228,,,5299316,[],CHEMBL1696603,Ratio of Kcat to Km for Escherichia coli BL21(DE3) VIM-2 W87F mutant beta-lactamase by spectrophotometer,B,Q5U7L7,W87F,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat/Km,/uM/s,,0.67,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Kcat/Km,/uM/s,,,0.67
1229,1229,,,5299317,[],CHEMBL1696602,Ratio of Kcat to Km for Escherichia coli BL21(DE3) VIM-2 W87A mutant beta-lactamase by spectrophotometer,B,Q5U7L7,W87A,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1337786,=,1,0,=,,Kcat/Km,/uM/s,,0.65,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Kcat/Km,/uM/s,,,0.65
1230,1230,,,5299354,[],CHEMBL1697232,Activity of Escherichia coli BL21(DE3) wild-type VIM-2 beta-lactamase by spectrophotometer,B,,,BAO_0000477,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,,Km,nM,,20000.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Km,uM,UO_0000065,,20.0
1231,1231,,,5299355,[],CHEMBL1697231,Activity of Escherichia coli BL21(DE3) VIM-2 W87F mutant beta-lactamase by spectrophotometer,B,Q5U7L7,W87F,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,,Km,nM,,18000.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Km,uM,UO_0000065,,18.0
1232,1232,,,5299356,[],CHEMBL1697230,Activity of Escherichia coli BL21(DE3) VIM-2 W87A mutant beta-lactamase by spectrophotometer,B,Q5U7L7,W87A,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687761,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1337786,=,1,1,=,,Km,nM,,23000.0,CHEMBL1255147,Escherichia coli,Metallo-beta-lactamase,562.0,,,Km,uM,UO_0000065,,23.0
1233,1233,,,5301723,[],CHEMBL1696767,Antimicrobial activity against Yersinia enterocolitica Biovar 1B 8081 after 20 hrs by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687764,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337805,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,,MIC,ug ml-1,UO_0000274,,0.75
1234,1234,,,5301731,[],CHEMBL1696768,Antimicrobial activity against beta-lactamase A-deficient Yersinia enterocolitica GY5717 after 20 hrs by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687764,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337805,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,,MIC,ug ml-1,UO_0000274,,0.5
1235,1235,,,5301739,[],CHEMBL1696769,Antimicrobial activity against beta-lactamase B-deficient Yersinia enterocolitica GY5542 after 20 hrs by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687764,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337805,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,,MIC,ug ml-1,UO_0000274,,0.75
1236,1236,,,5301747,[],CHEMBL1696770,Antimicrobial activity against beta-lactamase A and B-deficient Yersinia enterocolitica GY5718 after 20 hrs by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687764,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337805,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,,MIC,ug ml-1,UO_0000274,,0.5
1237,1237,,,5302155,[],CHEMBL1693515,Antimicrobial activity against Escherichia coli DH5alpha carrying Pseudomonas aeruginosa strain PS 297 IMP-18-pLBII after 18 hrs by microdilution broth method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338480,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
1238,1238,,,5302171,[],CHEMBL1693516,Antimicrobial activity against Escherichia coli DH5alpha carrying Pseudomonas aeruginosa strain PS 297 IMP-1-pLBII after 18 hrs by microdilution broth method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338480,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
1239,1239,,,5302187,[],CHEMBL1693517,Antimicrobial activity against Escherichia coli DH5alpha carrying empty pBC-SK after 18 hrs by microdilution broth method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338480,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
1240,1240,,,5302204,[],CHEMBL1693518,Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-18 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,,,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1338480,=,1,0,=,,Kcat,/s,,0.9,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,0.9
1241,1241,,,5302220,[],CHEMBL1693518,Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-18 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,,,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1338480,=,1,1,=,,Km,nM,,7000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,7.0
1242,1242,,,5302236,[],CHEMBL1693519,Ratio of Kcat to Km for Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP18 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1338480,=,1,0,=,,Kcat/Km,10'5/M/s,,1.3,CHEMBL612545,,Unchecked,,,,Kcat/Km,10'5/M/s,,,1.3
1243,1243,,,5302249,[],CHEMBL1693520,Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-1 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,,,BAO_0000481,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1338480,=,1,0,=,,Kcat,/s,,8.0,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,8.0
1244,1244,,,5302978,[],CHEMBL1693520,Activity of Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-1 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,,,BAO_0000477,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1338480,=,1,1,=,,Km,nM,,37000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,37.0
1245,1245,,,5302994,[],CHEMBL1693521,Ratio of Kcat to Km for Pseudomonas aeruginosa strain PS 297 metallo-beta-lactamase IMP-1 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis using 100 uM nitrocefin,B,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687833,Antimicrob Agents Chemother,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1338480,=,1,0,=,,Kcat/Km,10'5/M/s,,2.2,CHEMBL612545,,Unchecked,,,,Kcat/Km,10'5/M/s,,,2.2
1246,1246,,,5311393,[],CHEMBL1694463,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from human assessed as percentage of resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1337951,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
1247,1247,,,5311394,[],CHEMBL1694464,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from animals and food assessed as percentage of resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1337951,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
1248,1248,,,5311395,[],CHEMBL1695785,Antimicrobial activity against eaeA positive verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1337951,=,1,0,=,,Activity,%,,1.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,1.1
1249,1249,,,5311396,[],CHEMBL1695786,Antimicrobial activity against eaeA negative verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1337951,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
1250,1250,,,5312662,[],CHEMBL1696915,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli ECB2 plasmid carrying CMY-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
1251,1251,,,5312670,[],CHEMBL1697057,Antimicrobial activity against Escherichia coli TOP10 transformed with Enterobacter asburiae CIP 105006 plasmid carrying ACT-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1252,1252,,,5312678,[],CHEMBL1697056,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli DH10B plasmid carrying DHA-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
1253,1253,,,5312686,[],CHEMBL1697055,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli pGLK-1 plasmid carrying FOX-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1254,1254,,,5312694,[],CHEMBL1697054,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli ECB-1 plasmid carrying ACC-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
1255,1255,,,5312702,[],CHEMBL1697053,Antimicrobial activity against Escherichia coli TOP10 transformed with Escherichia coli EC-6 plasmid carrying AmpC-B2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
1256,1256,,,5312710,[],CHEMBL1697052,Antimicrobial activity against Escherichia coli TOP10 transformed by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
1257,1257,,,5312718,[],CHEMBL1696925,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli ECB2 plasmid carrying CMY-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1258,1258,,,5312726,[],CHEMBL1696921,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Enterobacter asburiae CIP 105006 plasmid carrying ACT-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1259,1259,,,5312734,[],CHEMBL1696920,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli DH10B plasmid carrying DHA-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1260,1260,,,5312742,[],CHEMBL1696919,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli pGLK-1 plasmid carrying FOX-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1261,1261,,,5312750,[],CHEMBL1696918,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli ECB-1 plasmid carrying ACC-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
1262,1262,,,5312758,[],CHEMBL1696917,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 transformed with Escherichia coli EC-6 plasmid carrying AmpC-B2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
1263,1263,,,5312766,[],CHEMBL1696916,Antimicrobial activity against OmpC/OmpF porin deficient Escherichia coli HB4 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1687794,Antimicrob Agents Chemother,2010.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338117,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
1264,1264,,Inactive,5319962,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,,1,0,,,Composite Activity - Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Score,,,,
1265,1265,,,5319963,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,=,1,0,=,,Composite Activity - Active,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Active,,,,0.0
1266,1266,,,5319964,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,=,1,0,=,,Composite Activity - Marginal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Marginal,,,,0.0
1267,1267,,Inactive,5319965,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,,1,0,,,Alkaline Phosphatase Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Activity Score,,,,
1268,1268,,,5319966,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,=,1,0,=,,Alkaline Phosphatase Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Index Value,,,,0.0
1269,1269,,,5319967,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,<,1,0,<,,Alkaline Phosphatase Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Number of Reports,,,,4.0
1270,1270,,Inactive,5319968,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,,1,0,,,SGOT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Activity Score,,,,
1271,1271,,,5319969,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,=,1,0,=,,SGOT Increase - Index Value,,,0.2,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Index Value,,,,0.2
1272,1272,,,5319970,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,<,1,0,<,,SGOT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Number of Reports,,,,4.0
1273,1273,,Inactive,5319971,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,,1,0,,,SGPT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Activity Score,,,,
1274,1274,,,5319972,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,=,1,0,=,,SGPT Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Index Value,,,,0.0
1275,1275,,,5319973,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,<,1,0,<,,SGPT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Number of Reports,,,,4.0
1276,1276,,Inactive,5319974,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,,1,0,,,LDH Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Activity Score,,,,
1277,1277,,,5319975,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,=,1,0,=,,LDH Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Index Value,,,,0.0
1278,1278,,,5319976,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,<,1,0,<,,LDH Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Number of Reports,,,,4.0
1279,1279,,Inactive,5319977,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,,1,0,,,GGT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Activity Score,,,,
1280,1280,,,5319978,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,=,1,0,=,,GGT Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Index Value,,,,0.0
1281,1281,,,5319979,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1341951,<,1,0,<,,GGT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Number of Reports,,,,4.0
1282,1282,,,6173657,[],CHEMBL1769835,Apparent permeability across human Caco2 cell membrane after 2 hrs by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1764994,Bioorg Med Chem,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1415524,=,1,0,=,,logPapp,,,-6.42,CHEMBL614058,Homo sapiens,Caco-2,9606.0,,,logPapp,,,,-6.42
1283,1283,,,6307781,[],CHEMBL1817008,Binding affinity to human PepT2 in SKTP cells,A,,,BAO_0000192,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1811879,Bioorg Med Chem,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1449143,=,1,1,=,,Ki,nM,,12600000.0,CHEMBL1743125,Homo sapiens,Solute carrier family 15 member 2,9606.0,,,Ki,mM,UO_0000065,,12.6
1284,1284,,,6307855,[],CHEMBL1817008,Binding affinity to human PepT2 in SKTP cells,A,,,BAO_0000192,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1811879,Bioorg Med Chem,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1449143,=,1,1,=,,Ki,nM,,12589254.12,CHEMBL1743125,Homo sapiens,Solute carrier family 15 member 2,9606.0,,,pKi(mM),,UO_0000065,,-1.1
1285,1285,,,7840580,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_bilirubinemia,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,0.0
1286,1286,,,7840581,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
1287,1287,,,7840582,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
1288,1288,,,7840583,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
1289,1289,,,7840584,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
1290,1290,,,7840585,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_hepatic failure,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,0.0
1291,1291,,,7840586,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_hepatic necrosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,0.0
1292,1292,,,7840587,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_hepatitis,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,1.0
1293,1293,,,7840588,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_hepatomegaly,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,0.0
1294,1294,,,7840589,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_jaundice,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,1.0
1295,1295,,,7840590,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
1296,1296,,,7840591,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
1297,1297,,,7840592,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_liver function tests abnormal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,0.0
1298,1298,,,7840593,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1541147,=,1,0,=,,HepSE_Combined Scores,,,2.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,2.0
1299,1299,,,7964816,[],CHEMBL1931392,Antibacterial activity against drug-sensitive Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,,MIC,ug.mL-1,,0.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.49
1300,1300,,,7964827,[],CHEMBL1931393,Antibacterial activity against drug-sensitive Staphylococcus aureus ATCC 6538 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,,MIC,ug.mL-1,,0.98,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.98
1301,1301,,,7964838,[],CHEMBL1931394,Antibacterial activity against drug-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,,MIC,ug.mL-1,,0.24,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.24
1302,1302,,,7964849,[],CHEMBL1931395,Antibacterial activity against drug-sensitive Bacillus subtilis ATCC 6633 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,,MIC,ug.mL-1,,15.63,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,15.63
1303,1303,,,7964860,[],CHEMBL1931396,Antibacterial activity against drug-sensitive Bacillus cereus ATCC 10876 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,,MIC,ug.mL-1,,31.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,31.25
1304,1304,,,7964871,[],CHEMBL1929939,Antibacterial activity against drug-sensitive Micrococcus luteus ATCC 10240 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564526,=,1,1,=,,MIC,ug.mL-1,,0.98,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,0.98
1305,1305,,Not Determined,7964956,[],CHEMBL1931392,Antibacterial activity against drug-sensitive Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1564526,,1,0,,,MBC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,,,,
1306,1306,,Not Determined,7964967,[],CHEMBL1931393,Antibacterial activity against drug-sensitive Staphylococcus aureus ATCC 6538 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1564526,,1,0,,,MBC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,,,,
1307,1307,,Not Determined,7964978,[],CHEMBL1931394,Antibacterial activity against drug-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1564526,,1,0,,,MBC,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,,,,
1308,1308,,Not Determined,7964989,[],CHEMBL1931395,Antibacterial activity against drug-sensitive Bacillus subtilis ATCC 6633 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1564526,,1,0,,,MBC,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MBC,,,,
1309,1309,,Not Determined,7965000,[],CHEMBL1931396,Antibacterial activity against drug-sensitive Bacillus cereus ATCC 10876 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1564526,,1,0,,,MBC,,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MBC,,,,
1310,1310,,Not Determined,7965011,[],CHEMBL1929939,Antibacterial activity against drug-sensitive Micrococcus luteus ATCC 10240 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL1926593,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1564526,,1,0,,,MBC,,,,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MBC,,,,
1311,1311,,,10833767,[],CHEMBL2014391,Antibacterial activity against Haemophilus influenzae ATCC 49766 after 20 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL2010707,Bioorg Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1631723,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
1312,1312,,,10861695,[],CHEMBL2026301,Ratio of MIC for wild type Escherichia coli JC7623 to MIC for acrAB-deficient Escherichia coli JZM120,F,,,BAO_0000193,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL2021919,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1639286,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
1313,1313,,,10861714,[],CHEMBL2026302,Ratio of MIC for wild type Escherichia coli TG1 to MIC for acrB-deficient Escherichia coli KAM3 by two-fold serial dilution method,F,,,BAO_0000193,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL2021919,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1639286,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
1314,1314,,,10861765,[],CHEMBL2026305,Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL2021919,Eur J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1639286,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.56
1315,1315,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [Ki>3uM],10996758,[],CHEMBL2076201,TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in SKPT cells,F,,,BAO_0000192,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL2074537,Eur J Pharm Biopharm,2005.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1670923,>,18,1,>,,Ki,nM,,3000.0,CHEMBL3325,Rattus norvegicus,"Oligopeptide transporter, kidney isoform",10116.0,,,Ki,uM,UO_0000065,,3.0
1316,1316,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [Ki=>5mM],11000377,[],CHEMBL2076202,TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in Caco-2 cells,F,,,BAO_0000192,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2074537,Eur J Pharm Biopharm,2005.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1670923,>,18,1,>,,Ki,nM,,5000000.0,CHEMBL4605,Homo sapiens,Oligopeptide transporter small intestine isoform,9606.0,,,Ki,mM,UO_0000065,,5.0
1317,1317,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [Ki=12.6mM],11000387,[],CHEMBL2076201,TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in SKPT cells,F,,,BAO_0000192,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2074537,Eur J Pharm Biopharm,2005.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1670931,=,18,1,=,,Ki,nM,,12600000.0,CHEMBL3325,Rattus norvegicus,"Oligopeptide transporter, kidney isoform",10116.0,,,Ki,mM,UO_0000065,,12.6
1318,1318,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [Ki=26mM],11000396,[],CHEMBL2076202,TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in Caco-2 cells,F,,,BAO_0000192,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2074537,Eur J Pharm Biopharm,2005.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,1670931,=,18,1,=,,Ki,nM,,26000000.0,CHEMBL4605,Homo sapiens,Oligopeptide transporter small intestine isoform,9606.0,,,Ki,mM,UO_0000065,,26.0
1319,1319,,,12088183,[],CHEMBL2167529,Antibacterial activity against Haemophilus influenzae ATCC 49766 incubated for 20 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL2163228,J Med Chem,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1736809,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
1320,1320,,Not Determined,12605848,[],CHEMBL3070138,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1839077,,1,0,,,MBC,,,,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MBC,,,,
1321,1321,,,12605867,[],CHEMBL3070138,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,,MIC,ug.mL-1,,0.98,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,0.98
1322,1322,,Not Determined,12605886,[],CHEMBL3070139,Antibacterial activity against Bacillus cereus ATCC 10876 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1839077,,1,0,,,MBC,,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MBC,,,,
1323,1323,,,12605905,[],CHEMBL3070139,Antibacterial activity against Bacillus cereus ATCC 10876 assessed as growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,,MIC,ug.mL-1,,31.25,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,31.25
1324,1324,,Not Determined,12607263,[],CHEMBL3070140,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1839077,,1,0,,,MBC,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MBC,,,,
1325,1325,,,12607282,[],CHEMBL3070140,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,,MIC,ug.mL-1,,15.63,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,15.63
1326,1326,,Not Determined,12607301,[],CHEMBL3070141,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1839077,,1,0,,,MBC,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,,,,
1327,1327,,,12607320,[],CHEMBL3070141,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,,MIC,ug.mL-1,,0.24,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.24
1328,1328,,Not Determined,12607339,[],CHEMBL3070142,Antibacterial activity against Staphylococcus aureus 14001 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1839077,,1,0,,,MBC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,,,,
1329,1329,,Not Determined,12607358,[],CHEMBL3070142,Antibacterial activity against Staphylococcus aureus 14001 assessed as growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1839077,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
1330,1330,,Not Determined,12607377,[],CHEMBL3070552,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1839077,,1,0,,,MBC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,,,,
1331,1331,,,12607396,[],CHEMBL3070552,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044979,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839077,=,1,1,=,,MIC,ug.mL-1,,0.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.49
1332,1332,,,12611345,[],CHEMBL3070117,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044844,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,,MIC,ug.mL-1,,0.49,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,0.49
1333,1333,,,12611357,[],CHEMBL3070118,Antibacterial activity against Bacillus cereus ATCC 10876 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044844,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,,MIC,ug.mL-1,,62.5,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,62.5
1334,1334,,,12611369,[],CHEMBL3070119,Antibacterial activity against Bacillus subtilis subsp. spizizenii ATCC 6633 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044844,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,,MIC,ug.mL-1,,0.49,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MIC,ug ml-1,UO_0000274,,0.49
1335,1335,,,12611381,[],CHEMBL3070120,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044844,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,,MIC,ug.mL-1,,0.24,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.24
1336,1336,,,12611393,[],CHEMBL3070121,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044844,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,,MIC,ug.mL-1,,1.95,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.95
1337,1337,,,12611405,[],CHEMBL3070122,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition after 18 hr by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3044844,Med Chem Res,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838425,=,1,1,=,,MIC,ug.mL-1,,0.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.49
1338,1338,,,13948437,[],CHEMBL3131967,Efflux ratio of permeability in pig LLC-PK1 cells transfected with human MDR1 at 1 uM by LC-MS/MS analysis,A,,,BAO_0000193,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3124885,J Med Chem,2014.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1973058,=,1,0,=,,Ratio,,,2.0,CHEMBL614577,Sus scrofa,LLC-PK1,9823.0,,,Ratio,,,,2.0
1339,1339,,,13948439,[],CHEMBL3131969,Apparent permeability from apical to basolateral side in pig LLC-PK1 cells by LC-MS/MS analysis,A,,,BAO_0002808,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3124885,J Med Chem,2014.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1973058,<,1,0,<,,Papp,ucm/s,,2.0,CHEMBL614577,Sus scrofa,LLC-PK1,9823.0,,,Papp,ucm/s,,,2.0
1340,1340,,references out of a total of 9,13991612,[],CHEMBL3137722,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (moderate),,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),,,,8.0
1341,1341,,,13991613,[],CHEMBL3137723,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1979364,=,1,0,=,,Hepatotoxicity (moderate),%,,29.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),%,UO_0000187,,29.1
1342,1342,,references out of a total of 9,13991614,[],CHEMBL3137724,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (acute),,,1.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (acute),,,,1.0
1343,1343,,,13991615,[],CHEMBL3137725,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,1979364,=,1,0,=,,Hepatotoxicity (acute),%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (acute),%,UO_0000187,,0.0
1344,1344,,references out of a total of 9,13991616,[],CHEMBL3137726,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (cytolytic),,,1.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cytolytic),,,,1.0
1345,1345,,references out of a total of 9,13991617,[],CHEMBL3137727,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (choleostasis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (choleostasis),,,,0.0
1346,1346,,references out of a total of 9,13991618,[],CHEMBL3137728,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (severe hepatitis),,,1.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (severe hepatitis),,,,1.0
1347,1347,,references out of a total of 9,13991619,[],CHEMBL3137729,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (chronic liver disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (chronic liver disease),,,,0.0
1348,1348,,references out of a total of 9,13991620,[],CHEMBL3137730,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (cirrhosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cirrhosis),,,,0.0
1349,1349,,references out of a total of 9,13991621,[],CHEMBL3137731,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (granulomatous hepatitis),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (granulomatous hepatitis),,,,0.0
1350,1350,,references out of a total of 9,13991622,[],CHEMBL3137732,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (association with vascular disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (association with vascular disease),,,,0.0
1351,1351,,references out of a total of 9,13991623,[],CHEMBL3137733,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (steatosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (steatosis),,,,0.0
1352,1352,,references out of a total of 9,13991624,[],CHEMBL3137734,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (malignant tumour),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (malignant tumour),,,,0.0
1353,1353,,references out of a total of 9,13991625,[],CHEMBL3137735,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,=,1,0,=,,Hepatotoxicity (benign tumour),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (benign tumour),,,,0.0
1354,1354,,,13991626,[],CHEMBL3137736,Animal toxicity known. [column 'TOXIC' in source],T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,,1,0,,,Hepatotoxicity (animal toxicity known),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (animal toxicity known),,,,
1355,1355,,,13991627,[],CHEMBL3137737,Presence of at least one case with successful reintroduction. [column 'REINT' in source],T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,,1,0,,,Hepatotoxicity (successful reintroduction),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (successful reintroduction),,,,
1356,1356,,,13991628,[],CHEMBL3137738,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,,1,0,,,Hepatotoxicity (comment),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (comment),,,,
1357,1357,,2 days,13991629,[],CHEMBL3137739,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,,1,0,,,Hepatotoxicity (time to onset),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (time to onset),,,,
1358,1358,,Allergic,13991630,[],CHEMBL3137740,Proposed mechanism(s) of liver damage. [column 'MEC' in source],T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,1979364,,1,0,,,Hepatotoxicity (mechanism),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (mechanism),,,,
1359,1359,,Not Active,14543571,[],CHEMBL3225251,Induction of membrane associated proteins mislocalization in Bacillus subtilis subsp. subtilis str. 168 assessed as reduction in GFP-MinD protein localization by fluorescence assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3217646,Medchemcomm,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,2075007,,1,0,,,Activity,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,,,,
1360,1360,,Not Active,14543591,[],CHEMBL3225260,Increase in bacterial membrane permeability in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 30 mins post dye addition by propidium iodide dye based flow cytometry,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3217646,Medchemcomm,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,2075007,,1,0,,,Activity,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,,,,
1361,1361,,,14543604,[],CHEMBL3225263,Induction of transmembrane potential loss in Bacillus subtilis subsp. subtilis str. 168 assessed as lambda575/lambda530 fluorescence emission intensity ratio at 1 times MIC pre-treated for 20 mins and measured 15 mins post dye addition by DiOC2 dye based flow cytometry (Rvb = 0.257 +/- 0.003 no unit),F,,,BAO_0000193,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3217646,Medchemcomm,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,2075007,=,1,0,=,,Ratio,,,0.306,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Ratio,,,,0.306
1362,1362,,,14543606,[],CHEMBL3225264,Antimicrobial activity against Bacillus subtilis subsp. subtilis str. 168 after 18 hrs by macro-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3217646,Medchemcomm,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,2075007,=,1,1,=,,MIC,nM,,20000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,20.0
1363,1363,,,15041078,[],CHEMBL3365482,Antimicrobial activity against Haemophilus influenzae ATCC 49766 after 20 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3351521,Bioorg Med Chem,2014.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2273814,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
1364,1364,,Not Active,15444971,[],CHEMBL3537398,Inhibition of human OAT3 expressed in CHO cells assessed as inhibition of fluorescein uptake at 500 uM over 20 mins relative to untreated-control,A,,,BAO_0000201,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3525990,Drug Metab Dispos,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,2470867,,1,0,,,Inhibition,%,,,CHEMBL1641348,Homo sapiens,Solute carrier family 22 member 8,9606.0,,,INH,,UO_0000187,,
1365,1365,,Not Active,15444995,[],CHEMBL3537397,Inhibition of mouse OAT3 expressed in CHO cells assessed as inhibition of fluorescein uptake at 500 uM over 20 mins relative to untreated-control,A,,,BAO_0000201,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3525990,Drug Metab Dispos,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,2470867,,1,0,,,Inhibition,%,,,CHEMBL2073672,Mus musculus,Solute carrier family 22 member 8,10090.0,,,INH,,UO_0000187,,
1366,1366,,Not Active,15445030,[],CHEMBL3537396,Inhibition of mouse OAT1 expressed in CHO cells assessed as inhibition of fluorescein uptake at 500 uM over 20 mins relative to untreated-control,A,,,BAO_0000201,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3525990,Drug Metab Dispos,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,2470867,,1,0,,,Inhibition,%,,,CHEMBL5653,Mus musculus,Solute carrier family 22 member 6,10090.0,,,INH,,UO_0000187,,
1367,1367,,Not Active,15445057,[],CHEMBL3537395,Binding affinity to mouse OAT3 expressed in CHO cells at 10 to 1000 uM measured over 20 mins,A,,,BAO_0000179,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3525990,Drug Metab Dispos,2013.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,2470867,,1,0,,,PPB,%,,,CHEMBL2073672,Mus musculus,Solute carrier family 22 member 8,10090.0,,,PB,,UO_0000187,,
1368,1368,,Active,15450682,[],CHEMBL3537355,Inhibition of recombinant human ABCC2 expressed in insect Sf21 cell plasma membrane vesicles assessed as inhibition of transporter-mediated [3H]-estradiol-17beta-glucuronide uptake by liquid scintillation counting analysis,A,,,BAO_0000201,BAO_0000249,cell membrane format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3526024,Drug Metab Dispos,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,2470124,,1,0,,,Inhibition,%,,,CHEMBL5748,Homo sapiens,Canalicular multispecific organic anion transporter 1,9606.0,,,INH,,UO_0000187,,
1369,1369,,Active,15450690,[],CHEMBL3537356,Inhibition of recombinant human ABCC3 expressed in baculovirus infected insect Sf21 cell plasma membrane vesicles assessed as inhibition of transporter-mediated [3H]-estradiol-17beta-glucuronide uptake by liquid scintillation counting analysis,A,,,BAO_0000201,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3526024,Drug Metab Dispos,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,2470124,,1,0,,,Inhibition,%,,,CHEMBL5918,Homo sapiens,Canalicular multispecific organic anion transporter 2,9606.0,,,INH,,UO_0000187,,
1370,1370,,Active,15452192,[],CHEMBL3537357,Inhibition of recombinant human ABCC4 expressed in baculovirus infected insect Sf21 cell plasma membrane vesicles assessed as inhibition of transporter-mediated [3H]-estradiol-17beta-glucuronide uptake by liquid scintillation counting analysis,A,,,BAO_0000201,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3526024,Drug Metab Dispos,2012.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,2470124,,1,0,,,Inhibition,%,,,CHEMBL1743128,Homo sapiens,Multidrug resistance-associated protein 4,9606.0,,,INH,,UO_0000187,,
1371,1371,,,15711328,[],CHEMBL3614411,Antimicrobial activity against Staphylococcus citreus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3612037,Eur J Med Chem,2015.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498859,=,1,1,=,,MIC,ug.mL-1,,600.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,mg/ml,UO_0000274,,0.6
1372,1372,,,15711337,[],CHEMBL3614852,Antimicrobial activity against Aeromonas hydrophila by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3612037,Eur J Med Chem,2015.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498859,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,,MIC,mg/ml,UO_0000274,,0.5
1373,1373,,,15711341,[],CHEMBL3614853,Antimicrobial activity against Escherichia coli by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL3612037,Eur J Med Chem,2015.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498859,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/ml,UO_0000274,,0.5
1374,1374,,,18132020,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3007018,=,1,0,=,,DILI_severity_class,,,5.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,5.0
1375,1375,,Less-Dili-Concern,18132620,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3007018,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
1376,1376,,,18323142,[],CHEMBL4134860,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
1377,1377,,,18323154,[],CHEMBL4134861,Antibacterial activity against linezolid and methicillin-resistant Staphylococcus aureus SAU-1 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
1378,1378,,,18323166,[],CHEMBL4134862,Antibacterial activity against methicillin-resistant Staphylococcus aureus 44674 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
1379,1379,,,18323178,[],CHEMBL4134863,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 69856 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
1380,1380,,,18323190,[],CHEMBL4134864,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 39249 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
1381,1381,,,18323202,[],CHEMBL4134865,Antibacterial activity against linezolid and methicillin-resistant Staphylococcus hominis alpha26 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,8.0
1382,1382,,,18323214,[],CHEMBL4134866,Antibacterial activity against linezolid and methicillin-resistant Staphylococcus epidermidis G1027 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
1383,1383,,,18323226,[],CHEMBL4134867,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis 3226 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
1384,1384,,,18323238,[],CHEMBL4134868,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,128.0
1385,1385,,,18323250,[],CHEMBL4134869,Antibacterial activity against linezolid and methicillin-resistant Enterococcus faecalis 4150 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,128.0
1386,1386,,,18323262,[],CHEMBL4134870,Antibacterial activity against linezolid and vancomycin-resistant Enterococcus faecium VRE2 assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4130476,Eur J Med Chem,2017.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3042084,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,128.0
1387,1387,,,18834997,[],CHEMBL4303810,Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits),F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4303122,,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3141267,=,52,0,=,,Hit score,,,0.29,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Hit score,,,,0.289985571
1388,1388,,,18931370,[],CHEMBL4325785,Protein binding in plasma (unknown origin),A,,,BAO_0000179,BAO_0000366,cell-free format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4321884,J Med Chem,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,3158161,=,1,1,=,,PPB,%,,31.5,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,33.0,31.5
1389,1389,,,18931396,[],CHEMBL4325787,Protein binding in immobilized human serum albumin by HPLC analysis,A,,,BAO_0000179,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4321884,J Med Chem,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,3158161,=,1,1,=,,PPB,%,,40.1,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,PB,%,UO_0000187,,40.1
1390,1390,,Not Determined,18931451,[],CHEMBL4325789,Binding affinity to human serum albumin assessed as change in dissociation constant pKa1 of compound in aqueous medium to presence of human serum albumin by UV-pH titration based spectrophotometric analysis,A,,,BAO_0002131,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4321884,J Med Chem,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3158161,,1,0,,,pKa,,,,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,pKa,,,,
1391,1391,,Not Determined,18931478,[],CHEMBL4325790,Binding affinity to human serum albumin assessed as change in dissociation constant pKa2 of compound in aqueous medium to presence of human serum albumin by UV-pH titration based spectrophotometric analysis,A,,,BAO_0002131,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4321884,J Med Chem,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3158161,,1,0,,,pKa,,,,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,pKa,,,,
1392,1392,,,18949660,[],CHEMBL4330708,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2490 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
1393,1393,,,18949666,[],CHEMBL4330709,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 254 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1024.0
1394,1394,,,18949672,[],CHEMBL4330710,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 231 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1024.0
1395,1395,,,18949678,[],CHEMBL4330711,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 417 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1024.0
1396,1396,,,18949684,[],CHEMBL4330712,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1344 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
1397,1397,,,18949690,[],CHEMBL4330713,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2901 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1398,1398,,,18949696,[],CHEMBL4330714,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3589 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
1399,1399,,,18949702,[],CHEMBL4330715,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 256 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
1400,1400,,,18949708,[],CHEMBL4330716,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3332 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
1401,1401,,,18949714,[],CHEMBL4330717,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3411 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1024.0
1402,1402,,,18949720,[],CHEMBL4330718,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1136 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
1403,1403,,,18949726,[],CHEMBL4330719,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2895 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
1404,1404,,,18949732,[],CHEMBL4330720,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2516 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
1405,1405,,,18949738,[],CHEMBL4330721,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3267 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
1406,1406,,,18949744,[],CHEMBL4330722,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 757 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
1407,1407,,,18949750,[],CHEMBL4330723,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1749 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1408,1408,,,18949756,[],CHEMBL4330724,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1402 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1409,1409,,,18949762,[],CHEMBL4330725,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2919 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1410,1410,,,18949768,[],CHEMBL4330726,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2728 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1411,1411,,,18949774,[],CHEMBL4330727,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1717 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1412,1412,,,18949780,[],CHEMBL4330728,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2224 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
1413,1413,,,18949786,[],CHEMBL4330729,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 358 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
1414,1414,,,18949792,[],CHEMBL4330730,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 3580 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1024.0
1415,1415,,,18949798,[],CHEMBL4330731,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 774 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1024.0
1416,1416,,,18949804,[],CHEMBL4330732,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 200 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
1417,1417,,,18949810,[],CHEMBL4330733,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 2973 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
1418,1418,,,18949816,[],CHEMBL4330734,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 85 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
1419,1419,,,18949822,[],CHEMBL4330735,Antibacterial activity against multidrug-resistant Staphylococcus aureus isolate 1449 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161239,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
1420,1420,,Not Active,18950107,[],CHEMBL4330698,"Antibacterial activity against multidrug-resistant Staphylococcus aureus ATCC 43300 infected in BALB/C mouse assessed as mouse survival at 50 mg/kg, ip bid measured after 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3161239,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1421,1421,,,18950109,[],CHEMBL4330696,"Antibacterial activity against multidrug-resistant Staphylococcus aureus ATCC 43300 infected in BALB/C mouse assessed as mouse survival at 25 mg/kg, ip bid measured on day 4 post infection (Rvb = 50%)",F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4330069,Eur J Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,3161239,=,1,0,=,,Activity,%,,70.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,70.0
1422,1422,,Active,19280842,[],CHEMBL4409128,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-44 at 128 to 256 ug/ml after 18 hrs by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4406847,Bioorg Med Chem,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3219778,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1423,1423,,,19451472,[],CHEMBL4433905,Permeability of the compound at pH 7.4 PBS buffer at 100 uM measured upto 6 hrs by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4433221,ACS Med Chem Lett,2019.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3249898,=,1,0,=,,Peff,10'-6 cm/s,,2.7,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,2.7
1424,1424,,,19955517,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4495564,,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,3341935,=,52,1,=,,Inhibition,%,,3.14,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,3.14
1425,1425,,,20147805,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4495565,,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,3359807,=,52,1,=,,Inhibition,%,,0.18,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,0.18
1426,1426,,Active,20668379,[],CHEMBL4620142,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as induction of changes in mass spectral profile of bacteria 1 times MIC uM by MALDI-TOF MS analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4619716,J Med Chem,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3480298,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
1427,1427,,,22071297,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4495565,,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://qudt.org/vocab/unit#Percent,3359807,=,52,1,=,,Inhibition,%,,0.18,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,0.18
1428,1428,,No. Measurements = 1,22086808,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4651402,,2021.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3493175,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
1429,1429,,No. Measurements = 1,22086809,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4651402,,2021.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3493175,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
1430,1430,,,22787438,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '6.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '6.0'}]",CHEMBL4708706,Permeability of the compound at pH 7.4 measured after 6 hrs by PAMPA method,A,,,BAO_0002808,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,,3538286,=,1,0,=,,permeability,10^-6 cm/s,,0.3,CHEMBL612558,,ADMET,,,,permeability,10^-6 cm/s,,,0.3
1431,1431,,,24415001,[],CHEMBL5047086,Antimicrobial activity against Klebsiella pneumoniae clinical isolate T2301 expressing NDM-1 assessed as inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5046233,Eur J Med Chem,2022.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783387,=,1,1,=,,MIC,ug.mL-1,,8.192,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug/L,UO_0000274,,8192.0
1432,1432,,,24415009,[],CHEMBL5047087,Antimicrobial activity against Escherichia coli clinical isolate T2228 expressing VIM-1 assessed as inhibition of bacterial growth by CLSI protocol based broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5046233,Eur J Med Chem,2022.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783387,=,1,1,=,,MIC,ug.mL-1,,1.024,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug/L,UO_0000274,,1024.0
1433,1433,,,24996144,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5231788,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909494,=,1,1,=,,MIC,ug.mL-1,,98.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,98.0
1434,1434,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25113993,[],CHEMBL5291867,Antagonist activity at human PPARG in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606.0,,,AC50,uM,UO_0000065,,30.0
1435,1435,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25114233,[],CHEMBL5291866,Agonist activity at human PPARG in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606.0,,,AC50,uM,UO_0000065,,30.0
1436,1436,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25118216,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,30.0
1437,1437,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120836,[],CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,,AC50,uM,UO_0000065,,30.0
1438,1438,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25122014,[],CHEMBL5291740,Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1439,1439,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25124190,[],CHEMBL5291890,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
1440,1440,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25126330,[],CHEMBL5291770,Binding affinity towards human CHRNA4 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1882,Homo sapiens,Neuronal acetylcholine receptor protein alpha-4 subunit,9606.0,,,AC50,uM,UO_0000065,,30.0
1441,1441,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25127108,[],CHEMBL5291722,"Compound was evaluated for inhibition of human ABCB11 in an in vitro assay with cellular components measured by filtration, liquid scintillation counting",F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,300000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,AC50,uM,UO_0000065,,300.0
1442,1442,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25129653,[],CHEMBL5291853,"Binding affinity towards human OPRK1 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1443,1443,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130835,[],CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
1444,1444,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25132041,[],CHEMBL5291823,Binding affinity towards human HTR2C in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1445,1445,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25133241,[],CHEMBL5291724,Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1446,1446,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25134449,[],CHEMBL5291727,Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1447,1447,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25135701,[],CHEMBL5291763,Compound was evaluated for inhibition of human CHRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
1448,1448,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25136922,[],CHEMBL5291767,Binding affinity towards human CHRM3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,AC50,uM,UO_0000065,,30.0
1449,1449,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25140578,[],CHEMBL5291781,"Binding affinity towards human DRD2 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1450,1450,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25141766,[],CHEMBL5291880,Binding affinity towards human SLC29A1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1997,Homo sapiens,Equilibrative nucleoside transporter 1,9606.0,,,AC50,uM,UO_0000065,,30.0
1451,1451,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25143941,[],CHEMBL5291737,Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1452,1452,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25145239,[],CHEMBL5291891,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
1453,1453,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25147063,[],CHEMBL5291854,Agonist activity at human OPRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1454,1454,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25148123,[],CHEMBL5291738,Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1455,1455,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25149364,[],CHEMBL5291824,"Compound was evaluated for inhibition of human HTR3A in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1899,Homo sapiens,Serotonin 3a (5-HT3a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1456,1456,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25150570,[],CHEMBL5291892,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
1457,1457,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25152716,[],CHEMBL5291726,Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1458,1458,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25154310,[],CHEMBL5291852,Binding affinity towards human OPRD1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1459,1459,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25159920,[],CHEMBL5291895,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
1460,1460,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25162352,[],CHEMBL5291750,Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1461,1461,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25163484,[],CHEMBL5291751,Binding affinity towards human AVPR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1790,Homo sapiens,Vasopressin V2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1462,1462,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25166423,[],CHEMBL5291870,Compound was evaluated for inhibition of human PTGS2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,AC50,uM,UO_0000065,,30.0
1463,1463,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25167523,[],CHEMBL5291791,Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
1464,1464,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25169565,[],CHEMBL5291810,Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1465,1465,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25170675,[],CHEMBL5291753,Binding affinity towards human BDKRB2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1466,1466,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25171612,[],CHEMBL5291758,Binding affinity towards human CCKBR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL298,Homo sapiens,Cholecystokinin B receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1467,1467,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25172988,[],CHEMBL5291803,Binding affinity towards human GHSR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4616,Homo sapiens,Ghrelin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1468,1468,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174631,[],CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,,AC50,uM,UO_0000065,,30.0
1469,1469,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25176068,[],CHEMBL5291850,"Binding affinity towards human NR3C1 in an in vitro cell free assay measured by filtration, radioactivity method",B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1470,1470,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25177225,[],CHEMBL5291744,Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL227,Homo sapiens,Type-1 angiotensin II receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1471,1471,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25178440,[],CHEMBL5291757,Binding affinity towards human CCKAR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1472,1472,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25179385,[],CHEMBL5291785,Binding affinity towards human EDNRA in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,AC50,uM,UO_0000065,,30.0
1473,1473,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25180757,[],CHEMBL5291777,Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1474,1474,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25183637,[],CHEMBL5291831,Binding affinity towards human MC3R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,AC50,uM,UO_0000065,,30.0
1475,1475,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25185573,[],CHEMBL5291858,Compound was evaluated for inhibition of human PDE4D in an in vitro cell free assay measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL288,Homo sapiens,Phosphodiesterase 4D,9606.0,,,AC50,uM,UO_0000065,,30.0
1476,1476,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25186741,[],CHEMBL5291834,Binding affinity towards human NPY1R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,AC50,uM,UO_0000065,,30.0
1477,1477,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25188347,[],CHEMBL5291846,Binding affinity towards human NR1I2 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,"{'bei': '12.29', 'le': '0.25', 'lle': '5.75', 'sei': '3.00'}",CHEMBL1436,CEFUROXIME,CHEMBL1436,5.21,0,http://www.openphacts.org/units/Nanomolar,3940043,=,1,1,=,,AC50,nM,,6100.0,CHEMBL3401,Homo sapiens,Pregnane X receptor,9606.0,,,AC50,uM,UO_0000065,,6.1
1478,1478,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25189419,[],CHEMBL5291833,Binding affinity towards human MLNR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1479,1479,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25190939,[],CHEMBL5291898,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
1480,1480,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25193768,[],CHEMBL5291899,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1481,1481,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25200784,[],CHEMBL5291921,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1482,1482,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25212756,[],CHEMBL5291809,Binding affinity towards human HRH1 in an in vitro assay measured by filtration,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1483,1483,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25213967,[],CHEMBL5291765,Antagonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
1484,1484,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25215173,[],CHEMBL5291764,Agonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
1485,1485,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25216195,[],CHEMBL5291814,Antagonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1486,1486,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25217252,[],CHEMBL5291813,Agonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1487,1487,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218242,[],CHEMBL5291901,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1488,1488,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25220125,[],CHEMBL5291735,Antagonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1489,1489,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25221323,[],CHEMBL5291734,Agonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1490,1490,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25222309,[],CHEMBL5291861,Antagonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,5.41,0,http://www.openphacts.org/units/Nanomolar,3940043,=,1,1,=,,AC50,nM,,3900.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,3.9
1491,1491,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25223221,[],CHEMBL5291860,Agonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1492,1492,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25223898,[],CHEMBL5291845,Antagonist activity at human NR1I2 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,4.89,0,http://www.openphacts.org/units/Nanomolar,3940043,=,1,1,=,,AC50,nM,,12999.9,CHEMBL3401,Homo sapiens,Pregnane X receptor,9606.0,,,AC50,uM,UO_0000065,,12.9999
1493,1493,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25224458,[],CHEMBL5291844,Agonist activity at human NR1I2 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3401,Homo sapiens,Pregnane X receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1494,1494,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25225395,[],CHEMBL5291817,Antagonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1495,1495,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25226565,[],CHEMBL5291816,Agonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1496,1496,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25227755,[],CHEMBL5291821,Antagonist activity at human HTR2B in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1497,1497,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25228949,[],CHEMBL5291819,Agonist activity at human HTR2B in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1498,1498,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25229998,[],CHEMBL5291729,Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1499,1499,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25230910,[],CHEMBL5291772,Antagonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1500,1500,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25231801,[],CHEMBL5291771,Agonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1501,1501,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25232432,[],CHEMBL5291747,Antagonist activity at rat Ar in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,30.0
1502,1502,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25232986,[],CHEMBL5291746,Agonist activity at rat Ar in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,30.0
1503,1503,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25233698,[],CHEMBL5291741,Agonist activity at human ADRB2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
1504,1504,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234131,[],CHEMBL5291796,Agonist activity at human GABRA1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,30.0
1505,1505,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234428,[],CHEMBL5291797,Antagonist activity at human GABRA1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1436,CEFUROXIME,CHEMBL1436,,0,http://www.openphacts.org/units/Nanomolar,3940043,>,1,1,>,,AC50,nM,,30000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,30.0
1506,1506,,,131536,[],CHEMBL642628,Hydrolysis rate constant at pH 9.6,A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1122808,J Med Chem,1984.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,316062,=,1,0,=,,k,hr-1,,0.107,CHEMBL612558,,ADMET,,,,k,hr-1,,,0.107
1507,1507,,,131537,[],CHEMBL642627,Hydrolysis rate constant at pH 10,A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1122808,J Med Chem,1984.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,316062,=,1,0,=,,k,hr-1,,0.217,CHEMBL612558,,ADMET,,,,k,hr-1,,,0.217
1508,1508,,,1490336,[],CHEMBL841787,Binding affinity against membrane transport protein PEPT1 in human Caco-2 cells,B,,,BAO_0000192,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1140305,J Med Chem,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,385308,>,1,1,>,,Ki,nM,,30000000.0,CHEMBL4605,Homo sapiens,Oligopeptide transporter small intestine isoform,9606.0,,,Ki,mM,UO_0000065,,30.0
1509,1509,,,1829026,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,=,1,0,=,,IC20,ug ml-1,,380.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC20,ug ml-1,UO_0000274,,380.0
1510,1510,,,1829027,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,0,>,,IC20,ug ml-1,,400.0,CHEMBL612582,,Osteoblast,,,,IC20,ug ml-1,UO_0000274,,400.0
1511,1511,,,1829028,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,ug ml-1,UO_0000274,,400.0
1512,1512,,,1829029,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL612582,,Osteoblast,,,,IC50,ug ml-1,UO_0000274,,400.0
1513,1513,,,1829031,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,=,1,0,=,,IC20,ug ml-1,,230.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC20,ug ml-1,UO_0000274,,230.0
1514,1514,,,1829032,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,ug ml-1,UO_0000274,,400.0
1515,1515,,,1829034,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,ug ml-1,UO_0000274,,400.0
1516,1516,,,1829036,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,=,1,0,=,,IC20,ug ml-1,,400.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC20,ug ml-1,UO_0000274,,400.0
1517,1517,,,1829037,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,=,1,0,=,,IC20,ug ml-1,,270.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC20,ug ml-1,UO_0000274,,270.0
1518,1518,,,1829038,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,ug ml-1,UO_0000274,,400.0
1519,1519,,,1829039,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,ug ml-1,UO_0000274,,400.0
1520,1520,,,1829040,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625748,>,1,0,>,,IC20,ug ml-1,,400.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC20,ug ml-1,UO_0000274,,400.0
1521,1521,,,1833685,[],CHEMBL856444,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,625855,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1522,1522,,,1833686,[],CHEMBL855426,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,625855,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1523,1523,,,1847480,[],CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC50,ug ml-1,UO_0000274,,0.25
1524,1524,,,1847488,[],CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC90,ug ml-1,UO_0000274,,0.5
1525,1525,,,1847496,[],CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,,MBC50,ug ml-1,,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MBC50,ug ml-1,UO_0000274,,0.5
1526,1526,,,1847504,[],CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,,MBC90,ug ml-1,,1.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MBC90,ug ml-1,UO_0000274,,1.0
1527,1527,,,1847516,[],CHEMBL919668,Increase in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,632003,=,1,0,=,,Activity,%,,13.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,13.0
1528,1528,,,1847524,[],CHEMBL919669,Decrease in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,632003,=,1,0,=,,Activity,%,,7.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,7.0
1529,1529,,,1847537,[],CHEMBL919653,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL856 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1530,1530,,,1847545,[],CHEMBL919654,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2394 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1531,1531,,,1847553,[],CHEMBL919655,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2414 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1532,1532,,,1847561,[],CHEMBL919656,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2492 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1533,1533,,,1847569,[],CHEMBL919657,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2526 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1534,1534,,,1847577,[],CHEMBL919658,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2554 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1535,1535,,,1847585,[],CHEMBL919659,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2588 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1536,1536,,,1847593,[],CHEMBL919660,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2622 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,,BBC,ug ml-1,,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,2.0
1537,1537,,,1847601,[],CHEMBL919661,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2639 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,,BBC,ug ml-1,,4.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,4.0
1538,1538,,,1847609,[],CHEMBL919662,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2640 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1539,1539,,,1847617,[],CHEMBL919663,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2664 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,,BBC,ug ml-1,,8.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,8.0
1540,1540,,,1847625,[],CHEMBL919664,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5204 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,=,1,0,=,,BBC,ug ml-1,,1.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,1.0
1541,1541,,,1847633,[],CHEMBL919665,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5254 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1542,1542,,,1847641,[],CHEMBL919666,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5256 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1543,1543,,,1847649,[],CHEMBL919667,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5258 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632003,>,1,0,>,,BBC,ug ml-1,,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,128.0
1544,1544,,,1847657,[],CHEMBL919110,Effect on biofilm formation of Staphylococcus lugdunensis assessed as percent non-biofilm forming isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,632003,=,1,0,=,,Activity,%,,80.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,80.0
1545,1545,,Not Active,1917552,[],CHEMBL894357,Antibacterial activity against multidrug resistant Staphylococcus aureus 49589,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1148734,J Med Chem,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,654119,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
1546,1546,,,1970808,[],CHEMBL896705,Antibacterial activity against Staphylococcus aureus by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1149559,Bioorg Med Chem Lett,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Millimeter,658475,=,1,1,=,,IZ,mm,,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,30.0
1547,1547,,,1970816,[],CHEMBL896706,Antibacterial activity against methicillin-resistant Staphylococcus aureus CMAH 0430 by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1149559,Bioorg Med Chem Lett,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Millimeter,658475,=,1,1,=,,IZ,mm,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,2.0
1548,1548,,,2060231,[],CHEMBL926687,Oral bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1141299,Bioorg Med Chem,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,683906,=,1,1,=,,F,%,,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,90.0
1549,1549,,,2126284,[],CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702301,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,16.0
1550,1550,,,2126285,[],CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702301,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,16.0
1551,1551,,,2126306,[],CHEMBL934998,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,702301,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
1552,1552,,,2126324,[],CHEMBL934999,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,702301,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
1553,1553,,,2126358,[],CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702301,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,16.0
1554,1554,,,2126359,[],CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702301,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,16.0
1555,1555,,,2126382,[],CHEMBL935001,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,702301,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
1556,1556,,,2126400,[],CHEMBL935002,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,702301,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
1557,1557,,,2307358,[],CHEMBL995399,Antimicrobial activity against Aeromonas caviae A324R expressing metallo-beta-lactamase IMP-19 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1137670,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783598,=,1,1,=,,MIC,ug.mL-1,,1024.0,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,,MIC,ug ml-1,UO_0000274,,1024.0
1558,1558,,,2307368,[],CHEMBL995396,Antimicrobial activity against Escherichia coli DH5alpha expressing pJDB2 containing Aeromonas caviae A324R metallo-beta-lactamase gene by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1137670,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783598,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1559,1559,,,2307378,[],CHEMBL995400,Antimicrobial activity against Escherichia coli DH5alpha expressing pIP19 containing Aeromonas caviae A324R metallo-beta-lactamase blaIMP-19 gene by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1137670,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783598,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1560,1560,,,2307388,[],CHEMBL995401,Antimicrobial activity against Escherichia coli DH5alpha by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1137670,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783598,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
1561,1561,,,2494966,[],CHEMBL982494,Sensitivity of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 30 ug/disk after 20 hrs,F,,,BAO_0003039,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Millimeter,779194,>=,1,1,>=,,IZ,mm,,18.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,18.0
1562,1562,,,2494970,[],CHEMBL982497,Resistance of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 30 ug/disk after 20 hrs,F,,,BAO_0003039,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Millimeter,779194,<=,1,1,<=,,IZ,mm,,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,14.0
1563,1563,,,2494974,[],CHEMBL982497,Resistance of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 30 ug/disk after 20 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,779194,=,1,0,=,,Activity,%,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,5.0
1564,1564,,,2575055,[],CHEMBL983705,Antimicrobial activity against Chryseobacterium indologenes NF16 isolate assessed as drug level at which microbial resistance was observed by agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742747,=,1,0,=,,Activity,ug ml-1,,64.0,CHEMBL613343,Chryseobacterium indologenes,Chryseobacterium indologenes,253.0,,,Activity,ug ml-1,UO_0000274,,64.0
1565,1565,,,2575063,[],CHEMBL983707,Antimicrobial activity against Escherichia coli HB101 harboring pBC-IND-5 plasmid containing metallo-beta-lactamase IND5 assessed as drug level at which microbial resistance was observed by agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742747,=,1,0,=,,Activity,ug ml-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,64.0
1566,1566,,,2575067,[],CHEMBL983706,Antimicrobial activity against Escherichia coli HB101 harboring pBC-SK plasmid assessed as drug level at which microbial resistance was observed by agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742747,=,1,0,=,,Activity,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,1.0
1567,1567,,,2575080,[],CHEMBL983708,Activity of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis,B,,,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,742747,=,1,1,=,,Km,nM,,25000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,25.0
1568,1568,,,2575085,[],CHEMBL983708,Activity of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis,B,,,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,742747,=,1,0,=,,Kcat,/s,,0.46,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,0.46
1569,1569,,,2575095,[],CHEMBL983709,Ratio of Kcat to Km of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis,B,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,742747,=,1,0,=,,Kcat/Km,/uM/s,,0.018,CHEMBL612545,,Unchecked,,,,Kcat/Km,/uM/s,,,0.018
1570,1570,,,2575106,[],CHEMBL983710,Ratio of Kcat to Km of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) assessed as substrate hydrolysis relative to control,B,,,BAO_0001103,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1155138,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,742747,=,1,0,=,,Activity,%,,2.1,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,2.1
1571,1571,,Not Active,2588940,[],CHEMBL965566,Inhibition of human recombinant MAOA by fluorimetric method,B,,,BAO_0000375,BAO_0000357,single protein format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1152129,J Med Chem,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,727125,,1,0,,,Activity,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,Activity,,,,
1572,1572,,,2661612,[],CHEMBL1035450,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 in peritoneal dialysis fluid administered as bolus dose 2 hrs after infection measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818119,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
1573,1573,,,2661613,[],CHEMBL1035451,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 in peritoneal dialysis fluid administered as bolus dose 2 hrs after infection measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818119,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1574,1574,,,2671453,[],CHEMBL1035433,Total body clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,821516,=,1,1,=,,CL,mL.min-1.kg-1,,0.89,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,0.89
1575,1575,,,2671454,[],CHEMBL1035434,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,821516,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.78,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,0.78
1576,1576,,,2727618,[],CHEMBL1051154,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM551 harboring active lytH and llm gene after 24 hrs by serial twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,,MIC,ug.mL-1,,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,200.0
1577,1577,,,2727619,[],CHEMBL1051155,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM563 harboring active lytH gene and inactive llm gene after 24 hrs by serial twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
1578,1578,,,2727620,[],CHEMBL1051156,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SR-17164 harboring inactive lytH gene and active llm gene after 24 hrs by serial twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,,MIC,ug.mL-1,,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,400.0
1579,1579,,,2727621,[],CHEMBL1055077,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1832 harboring inactive lytH and inactive llm gene after 24 hrs by serial twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,,MIC,ug.mL-1,,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,200.0
1580,1580,,,2727622,[],CHEMBL1055078,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1648 harboring inactive lytH gene and active llm gene after 24 hrs by serial twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,,MIC,ug.mL-1,,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,400.0
1581,1581,,,2727623,[],CHEMBL1055079,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1816 harboring inactive lytH and inactive llm gene after 24 hrs by serial twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
1582,1582,,,2727624,[],CHEMBL1055080,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1663 harboring inactive lytH gene and active llm gene after 24 hrs by serial twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,,MIC,ug.mL-1,,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,400.0
1583,1583,,,2727625,[],CHEMBL1055081,Antibacterial activity against high-level methicillin-resistant Staphylococcus aureus SRM1825 harboring inactive lytH and inactive llm gene after 24 hrs by serial twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153561,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830012,=,1,1,=,,MIC,ug.mL-1,,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,200.0
1584,1584,,,2990604,[],CHEMBL1043582,Hepatic clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,1,=,,CL,mL.min-1.kg-1,,0.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,0.1
1585,1585,,,2990673,[],CHEMBL1043588,Volume of distribution at steady state in human,A,,,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,1,=,,Vdss,L.kg-1,,0.12,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.12
1586,1586,,,2990734,[],CHEMBL1043580,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,1,=,,Fu,,,0.18,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Fu,,,,0.18
1587,1587,,,2993527,[],CHEMBL1043583,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.8,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,0.8
1588,1588,,,2994793,[],CHEMBL1043581,Total clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,1,=,,CL,mL.min-1.kg-1,,0.89,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,0.89
1589,1589,,,2994822,[],CHEMBL1043584,Oral bioavailability in human,A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,0,=,,F_fraction,,,0.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F_fraction,,,,0.9
1590,1590,,,2994867,[],CHEMBL1043586,Fraction escaping gut-wall elimination in human,A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,0,=,,Fg,,,0.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fg,,,,0.9
1591,1591,,,2996415,[],CHEMBL1043585,Fraction absorbed in human,A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,0,=,,Fa,,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fa,,,,1.0
1592,1592,,,2996544,[],CHEMBL1043587,Fraction escaping hepatic elimination in human,A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,861681,=,1,0,=,,Fh,,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fh,,,,1.0
1593,1593,,,3216056,[],CHEMBL1100460,"Dissociation constant, pKa of the compound",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,898129,=,1,0,=,,pKa,,,2.1,CHEMBL2362975,,No relevant target,,,,pKa,,,,2.1
1594,1594,,,3216147,[],CHEMBL1100461,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,898129,=,1,0,=,,logFu,,,0.11,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,logFu,,,,0.11
1595,1595,,,3217374,[],CHEMBL1100462,Volume of distribution at steady state in human,A,,,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1153781,Eur J Med Chem,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,898129,=,1,1,=,,Vdss,L.kg-1,,0.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,0.1
1596,1596,,,3385749,[],CHEMBL1221131,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus OC 4172 assessed as inhibition of growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929471,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
1597,1597,,,3385750,[],CHEMBL1221132,Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 assessed as inhibition of growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929471,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1598,1598,,Not Determined,3385751,[],CHEMBL1221133,Antimicrobial activity against Pseudomonas aeruginosa OC 4351 assessed as inhibition of growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,,1,0,,,MIC,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,,,,
1599,1599,,Not Determined,3385752,[],CHEMBL1221134,Antimicrobial activity against Pseudomonas aeruginosa OC 4354 assessed as inhibition of growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,,1,0,,,MIC,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,,,,
1600,1600,,,3385785,[],CHEMBL1221136,"Half life in immunocompetent SKH1 mouse plasma at 50 mg/kg, sc",A,,,BAO_0002115,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Hour,929471,=,1,1,=,,T1/2,hr,,0.2333,CHEMBL613589,Mus musculus,Plasma,10090.0,,,t1/2,min,UO_0000032,,14.0
1601,1601,,,3385786,[],CHEMBL1221141,"Tmax in immunocompetent SKH1 mouse plasma at 50 mg/kg, sc",A,,,BAO_0003037,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Hour,929471,=,1,1,=,,Tmax,hr,,0.125,CHEMBL613589,Mus musculus,Plasma,10090.0,,,Tmax,min,UO_0000032,,7.5
1602,1602,,,3385787,[],CHEMBL1221146,"fCmax in immunocompetent SKH1 mouse plasma at 50 mg/kg, sc",A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929471,=,1,0,=,,fCmax,ug ml-1,,19.0,CHEMBL613589,Mus musculus,Plasma,10090.0,,,fCmax,ug ml-1,UO_0000274,,19.0
1603,1603,,,3385788,[],CHEMBL1221151,"fAUC (0-infinity) in immunocompetent SKH1 mouse plasma at 50 mg/kg, sc",A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,1,=,,fAUC,ng.hr.mL-1,,9416.67,CHEMBL613589,Mus musculus,Plasma,10090.0,,,fAUC,min.ug/ml,,,565.0
1604,1604,,,3385837,[],CHEMBL1218872,"fT>MIC in Staphylococcus aureus Smith OC 4172 infected sc dosed SKH1 mouse at 50 mg/kg, sc administered twice at 1 and 3 hrs after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Hour,929471,=,1,0,=,,fT>MIC,hr,,2.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,hr,UO_0000032,,2.4
1605,1605,,,3385838,[],CHEMBL1218873,"fT>MIC in Staphylococcus aureus OC 8525 infected sc dosed SKH1 mouse at 50 mg/kg, sc administered twice at 1 and 3 hrs after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Hour,929471,=,1,0,=,,fT>MIC,hr,,0.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,hr,UO_0000032,,0.3
1606,1606,,,3385839,[],CHEMBL1218876,fT>MIC in Staphylococcus aureus OC 4172 infected sc dosed SKH1 mouse administered in 24 hrs dosing interval,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,929471,=,1,0,=,,fT>MIC,%,,10.2,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,10.2
1607,1607,,,3385840,[],CHEMBL1218877,fT>MIC in Staphylococcus aureus OC 8525 infected sc dosed SKH1 mouse administered in 24 hrs dosing interval,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,929471,=,1,0,=,,fT>MIC,%,,1.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,1.3
1608,1608,,,3385843,[],CHEMBL1218874,"fT>MIC in Pseudomonas aeruginosa OC 4351 infected sc dosed SKH1 mouse at 50 mg/kg, sc administered twice at 1 and 3 hrs after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Hour,929471,=,1,0,=,,fT>MIC,hr,,1.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,hr,UO_0000032,,1.5
1609,1609,,,3385844,[],CHEMBL1218875,"fT>MIC in Pseudomonas aeruginosa OC 4354 infected sc dosed SKH1 mouse at 50 mg/kg, sc administered twice at 1 and 3 hrs after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Hour,929471,=,1,0,=,,fT>MIC,hr,,0.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,hr,UO_0000032,,0.8
1610,1610,,,3385845,[],CHEMBL1218878,fT>MIC in Pseudomonas aeruginosa OC 4351 infected sc dosed SKH1 mouse administered in 24 hrs dosing interval,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,929471,=,1,0,=,,fT>MIC,%,,6.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,6.4
1611,1611,,,3385846,[],CHEMBL1218879,fT>MIC in Pseudomonas aeruginosa OC 4354 infected sc dosed SKH1 mouse administered in 24 hrs dosing interval,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,929471,=,1,0,=,,fT>MIC,%,,3.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,3.3
1612,1612,,,3385880,[],CHEMBL1218848,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected immunocompromized SKH1 mouse assessed as lesion volume at 1.6 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1181 mm3)",F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,Activity,mm3,,1090.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mm3,,,1090.0
1613,1613,,,3385881,[],CHEMBL1218849,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected immunocompromized SKH1 mouse assessed as lesion volume at 6.2 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1181 mm3)",F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,Activity,mm3,,987.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mm3,,,987.0
1614,1614,,,3385882,[],CHEMBL1218850,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected immunocompromized SKH1 mouse assessed as lesion volume at 25 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1181 mm3)",F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,Activity,mm3,,877.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mm3,,,877.0
1615,1615,,,3385883,[],CHEMBL1218851,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected immunocompromized SKH1 mouse assessed as lesion volume at 100 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1181 mm3)",F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,Activity,mm3,,781.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mm3,,,781.0
1616,1616,,,3385884,[],CHEMBL1218852,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected immunocompromized SKH1 mouse assessed as lesion volume at 1.6 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1535 mm3)",F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,Activity,mm3,,1383.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mm3,,,1383.0
1617,1617,,,3385885,[],CHEMBL1218853,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected immunocompromized SKH1 mouse assessed as lesion volume at 6.2 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1535 mm3)",F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,Activity,mm3,,1300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mm3,,,1300.0
1618,1618,,,3385886,[],CHEMBL1218854,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected immunocompromized SKH1 mouse assessed as lesion volume at 25 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1535 mm3)",F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,Activity,mm3,,1070.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mm3,,,1070.0
1619,1619,,,3385887,[],CHEMBL1218855,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected immunocompromized SKH1 mouse assessed as lesion volume at 100 mg/kg/day, sc measured after 48 hrs postinfection (Rvb = 1535 mm3)",F,,,BAO_0000181,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,Activity,mm3,,912.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mm3,,,912.0
1620,1620,,,3385924,[],CHEMBL1221155,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected in SKH1 mouse assessed as log change in bacterial colony forming unit per gram of skin tissue at 1.6 mg/kg/day, sc (Rvb = 1.6 deltalog CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,deltalog10CFU,,,-0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,-0.6
1621,1621,,,3385925,[],CHEMBL1221156,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected in SKH1 mouse assessed as log change in bacterial colony forming unit per gram of skin tissue at 6.2 mg/kg/day, sc (Rvb = 1.6 deltalog CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,deltalog10CFU,,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,1.6
1622,1622,,,3385926,[],CHEMBL1221157,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected in SKH1 mouse assessed as log change in bacterial colony forming unit per gram of skin tissue at 25 mg/kg/day, sc (Rvb = 1.6 deltalog CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,deltalog10CFU,,,-2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,-2.0
1623,1623,,,3385927,[],CHEMBL1221158,"Antimicrobial activity against methicillin-susceptible Staphylococcus aureus Smith OC 4172 infected in SKH1 mouse assessed as log change in bacterial colony forming unit per gram of skin tissue at 100 mg/kg/day, sc (Rvb = 1.6 deltalog CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,deltalog10CFU,,,-1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,-1.7
1624,1624,,,3385936,[],CHEMBL1221159,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected in SKH1 mouse assessed as log change in bacterial colony forming unit per gram of skin tissue at 1.6 mg/kg/day, sc (Rvb = 0.8 deltalog CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,deltalog10CFU,,,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,0.6
1625,1625,,,3385937,[],CHEMBL1221160,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected in SKH1 mouse assessed as log change in bacterial colony forming unit per gram of skin tissue at 6.2 mg/kg/day, sc (Rvb = 0.8 deltalog CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,deltalog10CFU,,,-1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,-1.2
1626,1626,,,3385938,[],CHEMBL1221161,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected in SKH1 mouse assessed as log change in bacterial colony forming unit per gram of skin tissue at 25 mg/kg/day, sc (Rvb = 0.8 deltalog CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,deltalog10CFU,,,-1.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,-1.3
1627,1627,,,3385939,[],CHEMBL1218847,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus OC 8525 infected in SKH1 mouse assessed as log change in bacterial colony forming unit per gram of skin tissue at 100 mg/kg/day, sc (Rvb = 0.8 deltalog CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,929471,=,1,0,=,,deltalog10CFU,,,-0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,-0.3
1628,1628,,,3385957,[],CHEMBL1218898,Protein binding in mouse plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1212762,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,929471,=,1,1,=,,PPB,%,,81.0,CHEMBL613589,Mus musculus,Plasma,10090.0,,,PPB,%,UO_0000187,,81.0
1629,1629,,,3473945,[],CHEMBL1262275,Activity of Beta-lactamase TEM-149 T182M mutant expressed in Escherichia coli HB101,B,,,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,960634,=,1,0,=,,Kcat,/s,,0.56,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,0.56
1630,1630,,,3477664,[],CHEMBL1262218,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolates isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1631,1631,,,3477676,[],CHEMBL1262218,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolates isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC90,ug ml-1,UO_0000274,,2.0
1632,1632,,,3477702,[],CHEMBL1262872,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU18 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,16.0
1633,1633,,,3477703,[],CHEMBL1262211,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU28 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,32.0
1634,1634,,,3477704,[],CHEMBL1262212,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU33 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,1.0
1635,1635,,,3477705,[],CHEMBL1262213,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU47 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,4.0
1636,1636,,,3477706,[],CHEMBL1262214,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU57 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,16.0
1637,1637,,,3477707,[],CHEMBL1262215,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU67 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,128.0
1638,1638,,,3477708,[],CHEMBL1262216,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU69 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,128.0
1639,1639,,,3477709,[],CHEMBL1262217,Antibacterial activity against methicillin-resistant mecA-positive Staphylococcus saprophyticus isolate TSU90 isolated from genitourinary tracts of acute cystitis patient after 24 hrs at 35 degC by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255354,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961073,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,64.0
1640,1640,,,3478632,[],CHEMBL1266063,"Antibacterial activity against Klebsiella pneumoniae isolate VA367 with blaKPC-3, qnrB19, blaTEM-1, blaSHV-11, blaSHV-12, aac(6')-1b genes by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
1641,1641,,,3478652,[],CHEMBL1266065,"Antibacterial activity against Escherichia coli J53 transconjugated with Klebsiella pneumoniae isolate VA367 containing blaKPC-3, qnrB19, blaTEM-1, blaSHV-11, aac(6')-1b genes by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
1642,1642,,,3478667,[],CHEMBL1266067,"Antibacterial activity against Klebsiella pneumoniae isolate VA375 with blaKPC-3, qnrA1, blaTEM-1, blaSHV-11 genes by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
1643,1643,,,3478682,[],CHEMBL1266069,"Antibacterial activity against Escherichia coli J53 transconjugated with Klebsiella pneumoniae isolate VA375 containing qnrA1, blaTEM-1, blaSHV-11genes by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
1644,1644,,,3478697,[],CHEMBL1266200,Antibacterial activity against Escherichia coli J53 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961614,<=,1,1,<=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
1645,1645,,,3489647,[],CHEMBL1265728,Activity of Aeromonas enteropelogenes Beta-lactamase TRU1,B,,,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,961251,=,1,0,=,,Kcat,/s,,0.55,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,0.55
1646,1646,,,3489648,[],CHEMBL1265732,Ratio of Kcat Km for Aeromonas enteropelogenes Beta-lactamase TRU1,B,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,961251,=,1,0,=,,Kcat/Km,10'3/M/s,,4.6,CHEMBL612545,,Unchecked,,,,Kcat/Km,10'3/M/s,,,4.6
1647,1647,,,3489759,[],CHEMBL1265728,Activity of Aeromonas enteropelogenes Beta-lactamase TRU1,B,,,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,961251,=,1,1,=,,Km,nM,,120000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,120.0
1648,1648,,,3489766,[],CHEMBL1265735,Activity of Aeromonas enteropelogenes Beta-lactamase TRU1 assessed as steady state compound hydrolysis rate,B,,,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,961251,=,1,0,=,,Kcat,/s,,0.25,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,0.25
1649,1649,,,3489767,[],CHEMBL1265735,Activity of Aeromonas enteropelogenes Beta-lactamase TRU1 assessed as steady state compound hydrolysis rate,B,,,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,961251,=,1,1,=,,Km,nM,,80000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,80.0
1650,1650,,,3489768,[],CHEMBL1265736,Ratio of Kcat Km for Aeromonas enteropelogenes Beta-lactamase TRU1 assessed as steady state compound hydrolysis rate,B,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255416,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,961251,=,1,0,=,,Kcat/Km,10'3/M/s,,3.1,CHEMBL612545,,Unchecked,,,,Kcat/Km,10'3/M/s,,,3.1
1651,1651,,,3495397,[],CHEMBL1262269,Antimicrobial activity against Serratia marcescens isolate CT-118 by broth macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,64.0
1652,1652,,,3495398,[],CHEMBL1262270,Antimicrobial activity against Escherichia coli HB101 expressing recombinant plasmid encoded TEM-149 by broth macrodilution method,F,,,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
1653,1653,,,3495399,[],CHEMBL1262271,Antimicrobial activity against Escherichia coli HB101 harboring empty vector pBK-SK by broth macrodilution method,F,,,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
1654,1654,,,3495400,[],CHEMBL1262272,Antimicrobial activity against Escherichia coli HB101 expressing plasmid encoded TEM-149 T182M mutant by broth macrodilution method,F,,,BAO_0002146,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
1655,1655,,,3495401,[],CHEMBL1262273,Activity of Beta-lactamase TEM-149 expressed in Escherichia coli HB101,B,,,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,960634,=,1,1,=,,Km,nM,,68000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,68.0
1656,1656,,,3495402,[],CHEMBL1262274,Ratio of Kcat to Km for Beta-lactamase TEM-149 expressed in Escherichia coli HB101,B,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,960634,=,1,0,=,,Kcat/Km,/uM/s,,0.032,CHEMBL612545,,Unchecked,,,,Kcat/Km,/uM/s,,,0.032
1657,1657,,,3495403,[],CHEMBL1262275,Activity of Beta-lactamase TEM-149 T182M mutant expressed in Escherichia coli HB101,B,,,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,960634,=,1,1,=,,Km,nM,,35000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,35.0
1658,1658,,,3495404,[],CHEMBL1262276,Ratio of Kcat to Km for Beta-lactamase TEM-149 T182M mutant expressed in Escherichia coli HB101,B,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,960634,=,1,0,=,,Kcat/Km,/uM/s,,0.016,CHEMBL612545,,Unchecked,,,,Kcat/Km,/uM/s,,,0.016
1659,1659,,,3495405,[],CHEMBL1262277,Activity of Beta-lactamase TEM-10,B,,,BAO_0000477,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,960634,=,1,1,=,,Km,nM,,417000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,417.0
1660,1660,,,3495406,[],CHEMBL1262278,Ratio of Kcat to Km for Beta-lactamase TEM-10,B,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,960634,=,1,0,=,,Kcat/Km,/uM/s,,0.03,CHEMBL612545,,Unchecked,,,,Kcat/Km,/uM/s,,,0.03
1661,1661,,,3495407,[],CHEMBL1262279,Antimicrobial activity against Enterobacter aerogenes isolate SS-13 by broth macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960634,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,64.0
1662,1662,,,3495408,[],CHEMBL1262273,Activity of Beta-lactamase TEM-149 expressed in Escherichia coli HB101,B,,,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,960634,=,1,0,=,,Kcat,/s,,2.2,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,2.2
1663,1663,,,3495409,[],CHEMBL1262277,Activity of Beta-lactamase TEM-10,B,,,BAO_0000481,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1255252,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,960634,=,1,0,=,,Kcat,/s,,12.5,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,12.5
1664,1664,,,3534763,[],CHEMBL1286720,Antimicrobial activity against beta-lactamase CTX-M-15-producing fluoroquinolone-resistant Escherichia coli FMV5825 expressing qnrB2 and aac(6')-Ib-cr and harboring gyrA Ser83Ile and Asp87Asn mutant gene and ParC Ser80Ile and Glu84Val mutant gene obtained from dog with urinary tract infection by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970680,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
1665,1665,,,3534785,[],CHEMBL1286723,Antimicrobial activity against Azide-resistant Escherichia coli J53 transconjugant harboring Escherichia coli DH5alpha-5825 qnrB2 gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970680,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
1666,1666,,,3534807,[],CHEMBL1286726,Antimicrobial activity against Azide-resistant Escherichia coli J53 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970680,<=,1,1,<=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
1667,1667,,,3566525,[],CHEMBL1278288,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1668,1668,,,3566526,[],CHEMBL1278287,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1669,1669,,,3566527,[],CHEMBL1278286,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1670,1670,,,3566528,[],CHEMBL1278285,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1671,1671,,,3566529,[],CHEMBL1278284,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1672,1672,,,3566530,[],CHEMBL1279494,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1673,1673,,,3566531,[],CHEMBL1279493,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1674,1674,,,3566532,[],CHEMBL1279492,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1675,1675,,,3566533,[],CHEMBL1279256,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1676,1676,,,3566534,[],CHEMBL1279255,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1677,1677,,,3567119,[],CHEMBL1278283,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1678,1678,,,3567120,[],CHEMBL1278282,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1679,1679,,,3567121,[],CHEMBL1278281,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1680,1680,,,3567122,[],CHEMBL1278280,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1681,1681,,,3567123,[],CHEMBL1278279,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1682,1682,,,3567124,[],CHEMBL1279254,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
1683,1683,,,3567125,[],CHEMBL1279253,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
1684,1684,,,3567126,[],CHEMBL1279252,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
1685,1685,,,3567127,[],CHEMBL1279251,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
1686,1686,,Not Determined,3567178,[],CHEMBL1279250,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
1687,1687,,Not Determined,3567179,[],CHEMBL1279248,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
1688,1688,,Not Determined,3567180,[],CHEMBL1279247,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
1689,1689,,Not Determined,3567181,[],CHEMBL1279246,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
1690,1690,,Not Determined,3567182,[],CHEMBL1279244,Antimicrobial activity against vancomycin-resistant Enterococcus sp. assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,Activity,,,,
1691,1691,,Not Determined,3567183,[],CHEMBL1279245,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,Activity,,,,
1692,1692,,Not Determined,3567184,[],CHEMBL1279243,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,Activity,,,,
1693,1693,,Not Determined,3567185,[],CHEMBL1279242,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,Activity,,,,
1694,1694,,Not Determined,3567186,[],CHEMBL1279241,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,Activity,,,,
1695,1695,,,3567677,[],CHEMBL1279226,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,4.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,4.9
1696,1696,,,3567680,[],CHEMBL1279230,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,6.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,6.2
1697,1697,,,3567684,[],CHEMBL1279229,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,7.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,7.7
1698,1698,,,3567685,[],CHEMBL1279227,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,7.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,7.7
1699,1699,,,3567686,[],CHEMBL1279228,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,7.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,7.8
1700,1700,,,3567688,[],CHEMBL1279237,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,8.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,8.6
1701,1701,,,3567692,[],CHEMBL1279236,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,11.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,11.5
1702,1702,,,3567703,[],CHEMBL1279240,Antimicrobial activity against CTX-M ESBL producing Escherichia coli assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,20.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,20.1
1703,1703,,,3567710,[],CHEMBL1279239,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,21.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,21.9
1704,1704,,,3567719,[],CHEMBL1279238,Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,25.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,25.8
1705,1705,,,3567724,[],CHEMBL1279185,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,83.3,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,83.3
1706,1706,,,3567725,[],CHEMBL1278289,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,88.9,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,88.9
1707,1707,,,3567726,[],CHEMBL1279225,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,89.7,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,89.7
1708,1708,,,3567727,[],CHEMBL1279183,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,94.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,94.1
1709,1709,,,3567728,[],CHEMBL1279184,Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,969581,=,1,0,=,,Activity,%,,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,100.0
1710,1710,,Not Determined,3567729,[],CHEMBL1279235,Antimicrobial activity against ESBL producing Klebsiella pneumoniae assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
1711,1711,,Not Determined,3567730,[],CHEMBL1279234,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
1712,1712,,Not Determined,3567731,[],CHEMBL1279233,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
1713,1713,,Not Determined,3567732,[],CHEMBL1279232,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
1714,1714,,Not Determined,3567733,[],CHEMBL1279231,Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
1715,1715,,Not Determined,3567734,[],CHEMBL1278290,Antimicrobial activity against Haemophilus influenzae assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
1716,1716,,Not Determined,3567735,[],CHEMBL1278291,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
1717,1717,,Not Determined,3567736,[],CHEMBL1278293,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
1718,1718,,Not Determined,3567737,[],CHEMBL1278294,Antimicrobial activity against Haemophilus influenzae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969581,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
1719,1719,,,3568125,[],CHEMBL1278618,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
1720,1720,,,3568134,[],CHEMBL1278617,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.12
1721,1721,,,3568143,[],CHEMBL1278619,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC 12403 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.12
1722,1722,,,3568152,[],CHEMBL1278620,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,2.0
1723,1723,,,3568161,[],CHEMBL1278621,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B6 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,1.0
1724,1724,,,3568170,[],CHEMBL1278622,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B7 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
1725,1725,,,3568179,[],CHEMBL1278623,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B8 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,1.0
1726,1726,,,3568188,[],CHEMBL1278624,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B10 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,1.0
1727,1727,,,3568197,[],CHEMBL1278625,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B12 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,1.0
1728,1728,,,3568206,[],CHEMBL1278626,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B40 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,1.0
1729,1729,,,3568215,[],CHEMBL1278627,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B60 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,1.0
1730,1730,,,3568224,[],CHEMBL1278628,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B68 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
1731,1731,,,3568233,[],CHEMBL1278629,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B502 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
1732,1732,,,3568242,[],CHEMBL1278630,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B503 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
1733,1733,,,3568251,[],CHEMBL1278631,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B513 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,1.0
1734,1734,,,3568260,[],CHEMBL1278632,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B514 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,1.0
1735,1735,,,3568269,[],CHEMBL1279013,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae B516 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
1736,1736,,,3568278,[],CHEMBL1279014,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 harboring PBP-2X Q557E mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,2.0
1737,1737,,,3568287,[],CHEMBL1279051,Antimicrobial activity against penicillin-resistant Streptococcus agalactiae ATCC BAA-611 harboring PBP-2X V405A mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275458,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
1738,1738,,,3571902,[],CHEMBL1279616,Antimicrobial activity against Escherichia coli DH5alpha by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
1739,1739,,,3571903,[],CHEMBL1279617,Antimicrobial activity against Escherichia coli DH5alpha harboring plasmid containing OXA-58-3 by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
1740,1740,,Not Determined,3571904,[],CHEMBL1279618,Antimicrobial activity against Escherichia coli DH5alpha harboring plasmid containing OXA-58-4 by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969633,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
1741,1741,,,3571905,[],CHEMBL1279619,Antimicrobial activity against Acinetobacter baumannii TVICU53 by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
1742,1742,,,3571906,[],CHEMBL1279620,Antimicrobial activity against Acinetobacter baumannii Ab290 by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
1743,1743,,,3571907,[],CHEMBL1279621,Antimicrobial activity against Acinetobacter baumannii Ab290 harboring TVICU53 plasmid by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
1744,1744,,,3571908,[],CHEMBL1279622,Antimicrobial activity against Acinetobacter baumannii Ab290 containing plasmid harboring OXA-58-3 by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
1745,1745,,Not Determined,3571909,[],CHEMBL1279623,Antimicrobial activity against Acinetobacter baumannii Ab290 containing plasmid harboring OXA-58-4 by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,969633,,1,0,,,MIC,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,,,,
1746,1746,,,3571910,[],CHEMBL1279624,Antimicrobial activity against Acinetobacter baumannii ATCC 15151T by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
1747,1747,,,3571911,[],CHEMBL1279625,Antimicrobial activity against Acinetobacter baumannii ATCC 15151T containing plasmid harboring OXA-58-3 by broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275439,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969633,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
1748,1748,,,3572199,[],CHEMBL1280784,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 3047-05 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1749,1749,,,3572200,[],CHEMBL1280785,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 5662-05 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1750,1750,,,3572201,[],CHEMBL1280786,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 6649-05 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.5
1751,1751,,,3572202,[],CHEMBL1280787,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 7490-03 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1752,1752,,,3572203,[],CHEMBL1280788,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IA isolate 9012-04 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1753,1753,,,3572204,[],CHEMBL1280789,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IB isolate 5436-03 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,1.0
1754,1754,,,3572205,[],CHEMBL1280790,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype II isolate 3776-04 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1755,1755,,,3572206,[],CHEMBL1280791,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype II isolate 9051-04 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1756,1756,,,3572207,[],CHEMBL1280792,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 3444-99 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1757,1757,,,3572208,[],CHEMBL1280793,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 7037-99 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1758,1758,,,3572209,[],CHEMBL1280794,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 3789-04 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,1.0
1759,1759,,,3572210,[],CHEMBL1280795,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 6138-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.5
1760,1760,,,3572211,[],CHEMBL1280796,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 7507-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.5
1761,1761,,,3572212,[],CHEMBL1280797,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and multilocus sequence type ST19 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.5
1762,1762,,,3572213,[],CHEMBL1280798,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype IV isolate 3454-03 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.5
1763,1763,,,3572214,[],CHEMBL1280799,Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 4214-03 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.5
1764,1764,,,3572215,[],CHEMBL1280800,Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 6149-03 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1765,1765,,,3572216,[],CHEMBL1280801,Antimicrobial activity against group B Streptococcus sp. 'group B' isolate 7368-04 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.5
1766,1766,,,3572217,[],CHEMBL1280802,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 3386-05 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.12
1767,1767,,,3572218,[],CHEMBL1280803,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 4857-03 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.5
1768,1768,,,3572219,[],CHEMBL1280804,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 5677-04 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,1.0
1769,1769,,,3572220,[],CHEMBL1280805,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype V isolate 9171-03 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
1770,1770,,,3572221,[],CHEMBL1280806,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and harboring empty vector by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,16.0
1771,1771,,,3572222,[],CHEMBL1280807,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607-03 expressing pbp2x Q557E mutant and harboring plasmid expressing wild-type pbp2x by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,2.0
1772,1772,,,3572223,[],CHEMBL1280808,Antimicrobial activity against group B Streptococcus sp. 'group B' serotype III isolate 8607 expressing multiple copies of wild-type pbp2x by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1275482,Antimicrob Agents Chemother,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969848,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,2.0
1773,1773,,Inconclusive,3666727,[],CHEMBL1614544,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,6.05,0,http://www.openphacts.org/units/Nanomolar,1163177,=,7,1,=,,Potency,nM,,891.3,CHEMBL1293235,Homo sapiens,Prelamin-A/C,9606.0,,,Potency,um,UO_0000065,,0.8913
1774,1774,,Active,4376504,[],CHEMBL1614174,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,4.35,0,http://www.openphacts.org/units/Nanomolar,1163177,=,7,1,=,,Potency,nM,,44668.4,CHEMBL1293248,Bacillus subtilis,4'-phosphopantetheinyl transferase ffp,1423.0,,,Potency,um,UO_0000065,,44.6684
1775,1775,,Inconclusive,4599204,[],CHEMBL1614275,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,4.75,0,http://www.openphacts.org/units/Nanomolar,1163177,=,7,1,=,,Potency,nM,,17740.7,CHEMBL1293234,Giardia intestinalis,"Putative fructose-1,6-bisphosphate aldolase",5741.0,,,Potency,um,UO_0000065,,17.7407
1776,1776,,,5079593,[],CHEMBL1614682,Volume of distribution at steady state in human after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614629,J Pharm Sci,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310942,=,1,1,=,,Vdss,L.kg-1,,0.11,CHEMBL612558,,ADMET,,,,Vdss,L/kg,UO_0000197,,0.11
1777,1777,,,5079611,[],CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310941,=,1,1,=,,Vdss,L.kg-1,,0.12,CHEMBL612558,,ADMET,,,,Vdss,L/kg,UO_0000197,,0.12
1778,1778,,,5079642,[],CHEMBL1614680,Volume of distribution at steady state in monkey after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614629,J Pharm Sci,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310942,=,1,1,=,,Vdss,L.kg-1,,0.13,CHEMBL612558,,ADMET,,,,Vdss,L/kg,UO_0000197,,0.13
1779,1779,,,5079766,[],CHEMBL1614672,Fraction unbound in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310941,=,1,1,=,,Fu,,,0.18,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fu,,,,0.18
1780,1780,,,5079865,[],CHEMBL1614676,Volume of distribution at steady state in rat after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614629,J Pharm Sci,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310942,=,1,0,=,,Vdss,mL/min/kg,,0.23,CHEMBL612558,,ADMET,,,,Vdss,mL/min/kg,,,0.23
1781,1781,,,5080085,[],CHEMBL1614678,Volume of distribution at steady state in dog after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614629,J Pharm Sci,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310942,=,1,1,=,,Vdss,L.kg-1,,0.27,CHEMBL612558,,ADMET,,,,Vdss,L/kg,UO_0000197,,0.27
1782,1782,,,5080780,[],CHEMBL1614681,Clearance in human after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614629,J Pharm Sci,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310942,=,1,1,=,,CL,mL.min-1.kg-1,,0.88,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,0.88
1783,1783,,,5080786,[],CHEMBL1614671,Clearance in human after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310941,=,1,1,=,,CL,mL.min-1.kg-1,,0.89,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,0.89
1784,1784,,,5081359,[],CHEMBL1614674,Half life in human after iv administration,A,,,BAO_0002115,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Hour,1310941,=,1,1,=,,T1/2,hr,,1.7,CHEMBL612558,,ADMET,,,,t1/2,h,UO_0000032,,1.7
1785,1785,,,5081459,[],CHEMBL1614679,Clearance in monkey after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614629,J Pharm Sci,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310942,=,1,1,=,,CL,mL.min-1.kg-1,,1.9,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,1.9
1786,1786,,,5081598,[],CHEMBL1614673,Mean residence time in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Hour,1310941,=,1,1,=,,MRT,hr,,2.2,CHEMBL612558,,ADMET,,,,MRT,h,UO_0000032,,2.2
1787,1787,,,5082033,[],CHEMBL1614677,Clearance in dog after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614629,J Pharm Sci,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310942,=,1,1,=,,CL,mL.min-1.kg-1,,3.5,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,3.5
1788,1788,,,5082568,[],CHEMBL1614675,Clearance in rat after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1614629,J Pharm Sci,2005.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1310942,=,1,1,=,,CL,mL.min-1.kg-1,,6.7,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,6.7
1789,1789,,,5086045,[],CHEMBL1633249,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313913,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
1790,1790,,,5086054,[],CHEMBL1633250,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate assessed as susceptible isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1313913,=,1,0,=,,Activity,%,,0.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,0.0
1791,1791,,,5086063,[],CHEMBL1633251,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1313913,=,1,0,=,,Activity,%,,235.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,235.0
1792,1792,,,5086072,[],CHEMBL1633249,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313913,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
1793,1793,,,5087897,[],CHEMBL1633673,Antimicrobial activity against Shigella sonnei UIH-1 expressing beta-lactamase CTX-M-64 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,16.0
1794,1794,,,5087898,[],CHEMBL1633677,Antimicrobial activity against rifampicin-resistant Escherichia coli X1037 transconjugant by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
1795,1795,,,5087899,[],CHEMBL1633788,Antimicrobial activity against rifampicin-resistant Escherichia coli X1037 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
1796,1796,,,5087900,[],CHEMBL1633792,Antimicrobial activity against Escherichia coli XL-1 Blue transconjugant harboring beta-lactamase CTX-M-64 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
1797,1797,,,5087901,[],CHEMBL1633796,Antimicrobial activity against Escherichia coli XL-1 Blue harboring plasmid CL1920 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629574,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314318,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
1798,1798,,,5096427,[],CHEMBL1635103,Ratio of drug level in patient bone with bone and joint infection to MIC90 for drug-susceptible Staphylococci,F,,,BAO_0000193,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1315469,=,1,0,=,,Ratio,,,5.0,CHEMBL345,,Nucleic Acid,,,,Ratio,,,,5.0
1799,1799,,,5096430,[],CHEMBL1635095,"Drug level in patient serum with bone and joint infection at 60 to 80 mg/kg/day, iv administered as continuous infusion for 42 days measured from day 2 to 10 by agar disk diffusion assay",A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1315469,=,1,0,=,,Drug uptake,mg/L,,63.0,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Drug uptake,mg/L,,,63.0
1800,1800,,,5096431,[],CHEMBL1635096,"Drug level in patient serum with bone and joint infection at 60 to 80 mg/kg/day, iv administered as continuous infusion for 42 days measured from day 11 to 21 by agar disk diffusion assay",A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1315469,=,1,0,=,,Drug uptake,mg/L,,57.0,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Drug uptake,mg/L,,,57.0
1801,1801,,,5096432,[],CHEMBL1635097,"Drug level in patient bone with bone and joint infection measured per gram of tissue at 60 to 80 mg/kg/day, iv administered as continuous infusion for 42 days measured on day 7 by agar disk diffusion assay",A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1315469,=,1,0,=,,Drug uptake,ug,,13.5,CHEMBL612558,,ADMET,,,,Drug uptake,ug,UO_0000023,,13.5
1802,1802,,,5096433,[],CHEMBL1635098,"Ratio of drug level in bone to serum in patient with bone and joint infection at 60 to 80 mg/kg/day, iv administered as continuous infusion for 42 days",A,,,BAO_0000193,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1315469,=,1,0,=,,Ratio,,,0.25,CHEMBL612558,,ADMET,,,,Ratio,,,,0.25
1803,1803,,,5096434,[],CHEMBL1635102,Ratio of drug level in patient serum with bone and joint infection to MIC90 for drug-susceptible Staphylococci,F,,,BAO_0000193,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1315469,=,1,0,=,,Ratio,,,60.75,CHEMBL345,,Nucleic Acid,,,,Ratio,,,,60.75
1804,1804,,,5096435,[],CHEMBL1635099,Antimicrobial activity against methicillin-susceptible Staphylococcus,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315469,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,mg/L,UO_0000274,,1.0
1805,1805,,,5096436,[],CHEMBL1635100,Antimicrobial activity against Streptococcus,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629646,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315469,=,1,1,=,,MIC90,ug.mL-1,,0.1,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC90,mg/L,UO_0000274,,0.1
1806,1806,,,5099543,[],CHEMBL1641042,Antimicrobial activity against Escherichia coli harboring plasmid pPCRScript by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313021,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
1807,1807,,,5099558,[],CHEMBL1641040,Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-18 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313021,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
1808,1808,,,5099562,[],CHEMBL1640892,Antimicrobial activity against Pseudomonas aeruginosa isolate 243-31C expressing beta-lactamase VIM-18 isolated from sputum of patient by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313021,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
1809,1809,,,5099568,[],CHEMBL1641041,Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313021,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
1810,1810,,,5099601,[],CHEMBL1641044,Ratio of MIC for Escherichia coli harboring beta-lactamase VIM-2 to MIC for Escherichia coli harboring beta-lactamase VIM-18,F,,,BAO_0000193,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1313021,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
1811,1811,,,5144969,[],CHEMBL1665423,Bactericidal activity against yafQ gene-deficient Escherichia coli K-12 BW25113 biofilm assessed as log reduction of viable cells after 24 hrs relative to wild-type Escherichia coli K-12 BW25113,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1326412,=,1,0,=,,FC,,,2400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2400.0
1812,1812,,Not Active,5144973,[],CHEMBL1665426,Bactericidal activity against Escherichia coli K-12 BW25113 biofilm harboring pCA24N ptac::yafQ plasmid assessed as log reduction of viable cells after 24 hrs pretreated with 5 uM of IPTG for 4 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1326412,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
1813,1813,,,5144975,[],CHEMBL1665425,Effect on survival of Escherichia coli K-12 BW25113 biofilm harboring pCA24N ptac::yafQ plasmid assessed as increase in cell survival after 24 hrs pretreated with 5 uM of IPTG for 4 hrs relative to wild-type Escherichia coli K-12 BW25114,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1326412,=,1,0,=,,FC,,,10000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,10000.0
1814,1814,,,5144979,[],CHEMBL1665427,Antimicrobial activity against Escherichia coli K-12 BW25113 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
1815,1815,,,5144983,[],CHEMBL1665428,Antimicrobial activity against yafQ gene-deficient Escherichia coli K-12 BW25113 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
1816,1816,,Active,5144987,[],CHEMBL1665430,Bactericidal activity against Escherichia coli K-12 BW25113 stationary-phase planktonic cell assessed as log reduction of viable cells after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1326412,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
1817,1817,,Active,5144988,[],CHEMBL1665429,Bactericidal activity against yafQ gene-deficient Escherichia coli K-12 BW25113 stationary-phase planktonic cell assessed as log reduction of viable cells after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1326412,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
1818,1818,,,5153316,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326465,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.063
1819,1819,,,5153330,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326465,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.125
1820,1820,,,5153344,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326465,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.25
1821,1821,,,5182551,[],CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,<=,1,1,<=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
1822,1822,,,5182557,[],CHEMBL1653406,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1823,1823,,,5182563,[],CHEMBL1653407,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1824,1824,,,5182569,[],CHEMBL1653408,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1825,1825,,,5182576,[],CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,64.0
1826,1826,,,5182582,[],CHEMBL1653410,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1827,1827,,,5182588,[],CHEMBL1653411,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1828,1828,,,5182594,[],CHEMBL1653412,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1829,1829,,,5182601,[],CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1830,1830,,,5182607,[],CHEMBL1653414,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
1831,1831,,,5182613,[],CHEMBL1653415,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1832,1832,,,5182619,[],CHEMBL1653416,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1833,1833,,,5182626,[],CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,64.0
1834,1834,,,5182632,[],CHEMBL1653418,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1835,1835,,,5182638,[],CHEMBL1653419,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
1836,1836,,,5182644,[],CHEMBL1653420,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
1837,1837,,,5182675,[],CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,32.0
1838,1838,,,5182690,[],CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,128.0
1839,1839,,,5182705,[],CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,2.0
1840,1840,,,5182709,[],CHEMBL1653443,Antibacterial activity against Escherichia coli assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,82.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,82.1
1841,1841,,,5182713,[],CHEMBL1653445,Antibacterial activity against Escherichia coli assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,3.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,3.8
1842,1842,,,5182717,[],CHEMBL1653447,Antibacterial activity against Escherichia coli assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,14.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,14.1
1843,1843,,,5182722,[],CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,2.0
1844,1844,,,5182727,[],CHEMBL1653451,Antibacterial activity against Klebsiella pneumoniae assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,91.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,91.4
1845,1845,,,5182732,[],CHEMBL1653453,Antibacterial activity against Klebsiella pneumoniae assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,1.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,1.8
1846,1846,,,5182737,[],CHEMBL1653578,Antibacterial activity against Klebsiella pneumoniae assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,6.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,6.8
1847,1847,,,5182743,[],CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC50,ug ml-1,UO_0000274,,8.0
1848,1848,,,5182748,[],CHEMBL1653582,Antibacterial activity against Klebsiella oxytoca assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,60.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,60.0
1849,1849,,,5182753,[],CHEMBL1654229,Antibacterial activity against Klebsiella oxytoca assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,23.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,23.0
1850,1850,,,5182758,[],CHEMBL1654231,Antibacterial activity against Klebsiella oxytoca assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,17.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,17.0
1851,1851,,,5182764,[],CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,128.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC50,ug ml-1,UO_0000274,,128.0
1852,1852,,,5182769,[],CHEMBL1654235,Antibacterial activity against Enterobacter cloacae assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,5.4,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,5.4
1853,1853,,,5182774,[],CHEMBL1654237,Antibacterial activity against Enterobacter cloacae assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,3.6,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,3.6
1854,1854,,,5182779,[],CHEMBL1654239,Antibacterial activity against Enterobacter cloacae assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,91.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,91.0
1855,1855,,,5182785,[],CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,8.0
1856,1856,,,5182790,[],CHEMBL1654243,Antibacterial activity against Proteus mirabilis assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,86.6,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,86.6
1857,1857,,,5182795,[],CHEMBL1654245,Antibacterial activity against Proteus mirabilis assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,8.4,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,8.4
1858,1858,,,5182800,[],CHEMBL1654366,Antibacterial activity against Proteus mirabilis assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,5.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,5.0
1859,1859,,,5182806,[],CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,128.0
1860,1860,,,5182811,[],CHEMBL1654370,Antibacterial activity against Serratia marcescens assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.9,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,0.9
1861,1861,,,5182816,[],CHEMBL1654372,Antibacterial activity against Serratia marcescens assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,0.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,0.0
1862,1862,,,5182821,[],CHEMBL1654374,Antibacterial activity against Serratia marcescens assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327125,=,1,0,=,,Activity,%,,99.1,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,99.1
1863,1863,,,5182827,[],CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,128.0
1864,1864,,,5182845,[],CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,128.0
1865,1865,,,5182851,[],CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,128.0
1866,1866,,,5182874,[],CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
1867,1867,,,5182881,[],CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1868,1868,,,5182888,[],CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,4.0
1869,1869,,,5183944,[],CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC90,ug.mL-1,,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1870,1870,,,5183963,[],CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC90,ug.mL-1,,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1871,1871,,,5183969,[],CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1872,1872,,,5183975,[],CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,64.0
1873,1873,,,5183980,[],CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,8.0
1874,1874,,,5183986,[],CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC90,ug ml-1,UO_0000274,,32.0
1875,1875,,,5183992,[],CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1876,1876,,,5183998,[],CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,16.0
1877,1877,,,5184004,[],CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1878,1878,,,5184010,[],CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1879,1879,,,5184016,[],CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1880,1880,,,5184022,[],CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,128.0
1881,1881,,,5184032,[],CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
1882,1882,,,5184039,[],CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
1883,1883,,,5184046,[],CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
1884,1884,,,5184053,[],CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
1885,1885,,,5184072,[],CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
1886,1886,,,5184078,[],CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,32.0
1887,1887,,,5184084,[],CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
1888,1888,,,5184089,[],CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
1889,1889,,,5184095,[],CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.5
1890,1890,,,5184101,[],CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
1891,1891,,,5184107,[],CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,1.0
1892,1892,,,5184113,[],CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,2.0
1893,1893,,,5184119,[],CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
1894,1894,,,5184125,[],CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,128.0
1895,1895,,,5184131,[],CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327125,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,64.0
1896,1896,,,5185365,[],CHEMBL1653792,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
1897,1897,,,5185366,[],CHEMBL1653792,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1898,1898,,,5185367,[],CHEMBL1653792,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,4.0
1899,1899,,,5185368,[],CHEMBL1653793,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
1900,1900,,,5185369,[],CHEMBL1653793,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,8.0
1901,1901,,,5185370,[],CHEMBL1653793,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type A TX01117 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,64.0
1902,1902,,,5185371,[],CHEMBL1653794,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.9
1903,1903,,,5185372,[],CHEMBL1653794,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1904,1904,,,5185373,[],CHEMBL1653794,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
1905,1905,,,5185374,[],CHEMBL1653795,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC,ug.mL-1,,2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.8
1906,1906,,,5185375,[],CHEMBL1653795,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,2.0
1907,1907,,,5185376,[],CHEMBL1653795,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type B using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
1908,1908,,,5185377,[],CHEMBL1653796,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
1909,1909,,,5185378,[],CHEMBL1653796,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1910,1910,,,5185379,[],CHEMBL1653796,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
1911,1911,,,5185380,[],CHEMBL1653797,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
1912,1912,,,5185381,[],CHEMBL1653797,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
1913,1913,,,5185382,[],CHEMBL1653797,Antibacterial activity against methicillin-susceptible and beta-lactamase-producing Staphylococcus aureus Type C using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
1914,1914,,,5185383,[],CHEMBL1653798,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.6
1915,1915,,,5185384,[],CHEMBL1653798,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1916,1916,,,5185385,[],CHEMBL1653798,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'5 CFU/ml standard inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
1917,1917,,,5185386,[],CHEMBL1653799,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
1918,1918,,,5185387,[],CHEMBL1653799,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
1919,1919,,,5185388,[],CHEMBL1653799,Antibacterial activity against methicillin-susceptible and beta-lactamase-negative Staphylococcus aureus ATCC 25923 using 5x10'7 CFU/ml high inoculum after 24 hrs by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
1920,1920,,,5185389,[],CHEMBL1653800,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at <= 1 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
1921,1921,,,5185390,[],CHEMBL1653801,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 2 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1922,1922,,,5185391,[],CHEMBL1653802,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 4 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1923,1923,,,5185392,[],CHEMBL1653803,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 8 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1924,1924,,,5185393,[],CHEMBL1653804,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 16 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1925,1925,,,5185394,[],CHEMBL1653805,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 32 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1926,1926,,,5185395,[],CHEMBL1653806,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at 64 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1927,1927,,,5185396,[],CHEMBL1653807,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'4 CFU/ml low inoculum assessed as bacterial growth inhibition at >= 128 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1928,1928,,,5185397,[],CHEMBL1653808,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at <= 1 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,89.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,89.0
1929,1929,,,5185398,[],CHEMBL1653904,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 2 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,5.0
1930,1930,,,5185399,[],CHEMBL1653905,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 4 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,6.0
1931,1931,,,5185400,[],CHEMBL1653906,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 8 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1932,1932,,,5185401,[],CHEMBL1653907,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 16 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1933,1933,,,5185402,[],CHEMBL1653908,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 32 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1934,1934,,,5185403,[],CHEMBL1653909,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at 64 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1935,1935,,,5185404,[],CHEMBL1653910,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'5 CFU/ml standard inoculum assessed as bacterial growth inhibition at >= 128 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1936,1936,,,5185405,[],CHEMBL1653911,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at <= 1 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,33.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,33.0
1937,1937,,,5185406,[],CHEMBL1653912,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 2 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,50.0
1938,1938,,,5185407,[],CHEMBL1653913,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 4 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,8.0
1939,1939,,,5185408,[],CHEMBL1653914,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 8 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,2.0
1940,1940,,,5185409,[],CHEMBL1662193,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 16 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,2.0
1941,1941,,,5185410,[],CHEMBL1662194,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 32 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,1.0
1942,1942,,,5185411,[],CHEMBL1662195,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at 64 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,3.0
1943,1943,,,5185412,[],CHEMBL1662196,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'6 CFU/ml intermediate inoculum assessed as bacterial growth inhibition at >= 128 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
1944,1944,,,5185413,[],CHEMBL1662197,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at <= 1 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,23.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,23.0
1945,1945,,,5185414,[],CHEMBL1662198,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 2 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,12.0
1946,1946,,,5185415,[],CHEMBL1662199,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 4 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,20.0
1947,1947,,,5185416,[],CHEMBL1662200,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 8 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,24.0
1948,1948,,,5185417,[],CHEMBL1662201,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 16 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,5.0
1949,1949,,,5185418,[],CHEMBL1662202,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 32 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,9.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,9.0
1950,1950,,,5185419,[],CHEMBL1662203,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at 64 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,3.0
1951,1951,,,5185420,[],CHEMBL1662204,Antibacterial activity against methicillin-susceptible Staphylococcus aureus using 5x10'7 CFU/ml high inoculum assessed as bacterial growth inhibition at >= 128 ug/ml,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1327149,=,1,0,=,,Activity,%,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,2.0
1952,1952,,,5185421,[],CHEMBL1662205,"Drug level in human serum at 1 g, iv after 4 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,0,=,,Drug uptake,ug ml-1,,17.0,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Drug uptake,ug ml-1,UO_0000274,,17.0
1953,1953,,,5185422,[],CHEMBL1662206,Drug level in bone of methicillin-susceptible Staphylococcus aureus infected human after 60 mins,A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1649557,Antimicrob Agents Chemother,2009.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327149,=,1,0,=,,Drug uptake,ug ml-1,,6.9,CHEMBL612558,,ADMET,,,,Drug uptake,ug ml-1,UO_0000274,,6.9
1954,1954,,,5311373,[],CHEMBL1694463,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from human assessed as percentage of resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1337950,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
1955,1955,,,5311374,[],CHEMBL1694464,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from animals and food assessed as percentage of resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1337950,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
1956,1956,,,5311375,[],CHEMBL1695785,Antimicrobial activity against eaeA positive verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1337950,=,1,0,=,,Activity,%,,1.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,1.1
1957,1957,,,5311376,[],CHEMBL1695786,Antimicrobial activity against eaeA negative verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1687790,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://qudt.org/vocab/unit#Percent,1337950,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
1958,1958,,,5314137,[],CHEMBL1690796,Antimicrobial activity against methicillin-resistant and tetracycline-sensitive Staphylococcus aureus COLn,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1687797,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338137,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
1959,1959,,,5314138,[],CHEMBL1690797,"Antimicrobial activity against methicillin-, tetracycline-susceptible and chromosomal mecA deficient Staphylococcus aureus COLnex",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1687797,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338137,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
1960,1960,,,5314139,[],CHEMBL1690798,"Antimicrobial activity against beta-lactam-resistant and chromosomal mecA deficient Staphylococcus aureus CRB harboring PBP4 E183A F241R, GdpP N182K and AcrB I960V mutant genes selected after 21 days of serial passage in ceftobiprole",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1687797,Antimicrob Agents Chemother,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338137,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
1961,1961,,drug-induced liver injury reported,5317184,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1340930,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
1962,1962,,drug-induced liver injury reported,5318135,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1340930,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
1963,1963,,no drug-induced liver injury reported,5319086,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1340930,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
1964,1964,,Data Not Available,5326146,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,Composite Activity - Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Score,,,,
1965,1965,,,5326147,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,=,1,0,=,,Composite Activity - Active,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Active,,,,0.0
1966,1966,,,5326148,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,=,1,0,=,,Composite Activity - Marginal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Marginal,,,,0.0
1967,1967,,Data Not Available,5326149,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,Alkaline Phosphatase Increase - Index Value,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Index Value,,,,
1968,1968,,Data Not Available,5326150,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,Alkaline Phosphatase Increase - Number of Reports,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Number of Reports,,,,
1969,1969,,Data Not Available,5326151,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,Alkaline Phosphatase Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Activity Score,,,,
1970,1970,,Data Not Available,5326152,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,SGOT Increase - Index Value,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Index Value,,,,
1971,1971,,Data Not Available,5326153,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,SGOT Increase - Number of Reports,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Number of Reports,,,,
1972,1972,,Data Not Available,5326154,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,SGOT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Activity Score,,,,
1973,1973,,Data Not Available,5326155,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,SGPT Increase - Index Value,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Index Value,,,,
1974,1974,,Data Not Available,5326156,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,SGPT Increase - Number of Reports,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Number of Reports,,,,
1975,1975,,Data Not Available,5326157,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,SGPT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Activity Score,,,,
1976,1976,,Data Not Available,5326158,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,LDH Increase - Index Value,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Index Value,,,,
1977,1977,,Data Not Available,5326159,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,LDH Increase - Number of Reports,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Number of Reports,,,,
1978,1978,,Data Not Available,5326160,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,LDH Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Activity Score,,,,
1979,1979,,Data Not Available,5326161,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,GGT Increase - Index Value,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Index Value,,,,
1980,1980,,Data Not Available,5326162,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,GGT Increase - Number of Reports,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Number of Reports,,,,
1981,1981,,Data Not Available,5326163,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1341935,,1,0,,,GGT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Activity Score,,,,
1982,1982,,Active,5372620,[],CHEMBL1737991,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1360075,,7,1,,,Potency,nM,,79432.8,CHEMBL5896,Homo sapiens,Lysine-specific demethylase 4A,9606.0,,,Potency,uM,UO_0000065,,79.4328
1983,1983,,Active,5573085,[],CHEMBL1613775,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771, AID488772]",F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,,Potency,nM,,11917.3,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,11.9173
1984,1984,,Active,5762704,[],CHEMBL1738442,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,,Potency,nM,,2993.5,CHEMBL6032,Homo sapiens,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3",9606.0,,,Potency,uM,UO_0000065,,2.9935
1985,1985,,inconclusive,5777022,[],CHEMBL1614279,"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]",F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,,Potency,nM,,756.9,CHEMBL5686,Trypanosoma brucei,6-phospho-1-fructokinase,5691.0,,,Potency,uM,UO_0000065,,0.7569
1986,1986,,inconclusive,5795957,[],CHEMBL1738610,PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,,Potency,nM,,79432.8,CHEMBL1741193,Homo sapiens,Chromobox protein homolog 1,9606.0,,,Potency,uM,UO_0000065,,79.4328
1987,1987,,,6260304,[],CHEMBL1798346,"In-vivo plasma to lung partition coefficients of the compound, logP(lung) in rat",A,,,BAO_0000179,BAO_0000366,cell-free format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1795228,Eur J Med Chem,2008.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1437365,=,1,0,=,,logP(lung),,,-0.78,CHEMBL612558,,ADMET,,,,logP(lung),,,,-0.78
1988,1988,,inconclusive,6425412,[],CHEMBL1794311,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1163177,,7,1,,,Potency,nM,,35481.3,CHEMBL1977,Homo sapiens,Vitamin D receptor,9606.0,,,Potency,uM,UO_0000065,,35.4813
1989,1989,,inconclusive,6436628,[],CHEMBL1794311,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,,Potency,nM,,79432.8,CHEMBL1977,Homo sapiens,Vitamin D receptor,9606.0,,,Potency,uM,UO_0000065,,79.4328
1990,1990,,inconclusive,6438967,[],CHEMBL1794311,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1360075,,7,1,,,Potency,nM,,100000.0,CHEMBL1977,Homo sapiens,Vitamin D receptor,9606.0,,,Potency,uM,UO_0000065,,100.0
1991,1991,,inconclusive,6786573,[],CHEMBL1794424,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1360075,,7,1,,,Potency,nM,,50118.7,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,50.1187
1992,1992,,inconclusive,6813747,[],CHEMBL1794424,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,,Potency,nM,,11917.3,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,11.9173
1993,1993,,inconclusive,7065583,[],CHEMBL1794499,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1309136,,7,1,,,Potency,nM,,26679.5,CHEMBL1795091,Homo sapiens,Regulator of G-protein signaling 4,9606.0,,,Potency,uM,UO_0000065,,26.6795
1994,1994,,inactive,7270107,[],CHEMBL1794584,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",F,,,BAO_0000186,BAO_0000019,assay format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1201862,,,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,http://www.openphacts.org/units/Nanomolar,1360075,,7,1,,,Potency,nM,,3981.1,CHEMBL1293258,Homo sapiens,Mothers against decapentaplegic homolog 3,9606.0,,,Potency,uM,UO_0000065,,3.9811
1995,1995,,,7841438,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1541168,=,1,0,=,,HepSE_bilirubinemia,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,0.0
1996,1996,,,7841439,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1541168,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
1997,1997,,,7841440,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1541168,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
1998,1998,,,7841441,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1541168,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
1999,1999,,,7841442,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1435,CEFAZOLIN,CHEMBL1435,,0,,1541168,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
